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Abstract 
 
Monoclonal antibodies (mAbs) have been essential tools in the elucidation of the 
immune system of mammals, and their application to identify surface molecules on 
leukocytes have allowed important functions of these cell to be identified (such as receptors 
that bind antigens, ligands involved in cell to cell signaling or in initiating immune response 
activity). Not only have mAbs been used to discriminate cells during different stages of cell 
development, but have also assisted in understanding the dynamics of molecules expressed 
during functional processes. Such molecules detected on human leukocytes are called human 
leukocyte differentiation antigens or HLDA. In order to group the antibodies that detect 
similar molecules and have similar patterns of reaction, immunologists have organised the 
mAbs that bind to these antigens into Clusters of Differentiation (CD). So far, there are 
about 350 leukocyte surface molecules detected by mAbs with a CD nomenclature for 
human leukocytes (www.hcdm.org).  
In fish immunology there is a great need to produce mAbs that are able to 
differentiate the various components of the fish immune system to assist in the elucidation 
of the fish immune system. The present study was an endeavour to develop and characterise 
mAbs that could be accredited to such scheme. A better understanding of the fish immune 
system is urgently required so that effective strategies of control can be developed for 
significant diseases during fish farming. 
Monoclonal antibodies were prepared by immunizing mice with thymic leukocytes 
from rainbow trout. The leukocytes were activated with the lectin Concanavalin A to 
promote the activation and proliferation of the target T-cell population. The selection of 
clones producing antibodies during screening was performed on the basis of the response of 
the supernatant from hybridomas using three consecutive assays. First, selection was 
determined by the positive staining of cells from the thymus in a Dot blot assay. Secondary 
screening was performed by means of flow cytometry (FCM) and the criterion for selection 
was the preferential detection of leukocytes gated in the lymphocyte region. Finally, the 
positive supernatants from hybridomes were evaluated to determine their effectiveness in the 
detection of modifications in the labelled cells during a multiple way activation by detection 
of foreign histocompatibility complex enhanced with mitogens. 
Monoclonal antibody TcOm15 was selected from 564 hybridomas produced and 
then used to stain cells from various Rainbow Trout tissues. It was clear from FCM, 
microscopy and Western blot analysis that mAb TcOm15 not only reacted with thymic cells 
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but also with cells from other tissues. Differential staining of cells with mAb TcOm15 was 
observed with 27.1 ±1.4 % of leukocytes from peripheral blood leukocytes (PBL) stained in 
comparison to 2.0 ±0.2 % from the thymus, 13.8 ±0.4 % from the spleen, and 5.6 ±0.6 % 
cells stained from head kidney. The labeled cells showed characteristics of lymphocytes and 
monocytes, presenting a distinctive staining in immunohistochemistry and confocal 
microscopy.  
Western blot analysis, using electrophoresed proteins under denaturing conditions 
with leukocytes from several different tissues, showed that mAb TcOm15 did not detect a 
single protein. At least three proteins appeared to be identified by the mAb at 105, 160 and 
200 kDa. The proteins were identified as α Actinin-4, non-erythroid Spectrin αII chain or Ig-
like protein and non-muscle Myosin (MYH10) by MALDI-TOF analysis. Three of these 
identities are for compositional molecules for the cytoskeleton of different types of cells, and 
one it is associated to immunoglobulin superfamily. The identification of these proteins by 
mAb TcOm15 suggests an ability of this mAb to detect a specific function, possibly related 
with the synchronicity of expression or interaction of cytoskeleton-membrane proteins 
forming a multiprotein complex. Another possibility is as a carrier role for a protein during 
interactions.  
Colocalization of the mAb with F actin from the cytoskeleton was also observed 
suggesting the possibility that mAb TcOm15 detects a specific site in a multi-protein 
complex from the cytoskeleton. The molecule detected showed down-regulation in a dose 
dependant way with Concanavalin A and the expression was almost lost following 
stimulation of cells with phorbol 12-myristate 13-acetate stimulation. Leukocytes from the 
PBL and thymus up-regulated the expression of the TcOm15 molecule under mitogenic 
conditions in vitro, and results from in vivo experiments suggested the possibility of up-
regulation on thymic cells. 
In conclusion, the results obtained in the present study provide information on a 
potentially useful marker (mAb TcOm15) for a cytoskeleton-membrane antigen that is 
modulated during stimulation of teleost lymphocytes. Additionally, this may enable insights 
into the relationship between cytoskeletal proteins and membrane associated 
immunoglobulin. Future research is necessary in order to explain this relationship and to 
determine the functional participation of the TcOm15 molecule during the activation of 
rainbow trout cells. 
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Chapter 1 General Introduction 
1.1 Overview 
Aquaculture production has expanded during recent years as a result of 
increased food demands. Given the artificial conditions under which fish are cultivated 
for this purpose, the organisms suffer a number of physiological constraints that result 
in regular infectious disease outbreaks. Therefore, one of the major concerns and a 
significant investment cost to the industry is related to preserving the health of the fish 
stocks. Avoidance of stress, immunostimulation and vaccination (among others) play 
an important part in the biosecurity programs used to help prevent the negative 
impacts of infective organisms in fish rearing systems (Yoshimizu, 2003; Pruder, 2004). 
In order to implement effective disease control strategies, efforts are being made to 
develop ways of enhancing the processes that enable the fish to limit or eliminate the 
infectious agents. The immune response is the process by which organisms, including 
fish, preserve homeostasis and defend themselves against disease.  However, practical 
approaches to improve the health management of fish require fundamental knowledge 
on the immune response of fish (Siwicki et al., 1994; Lorenzen et al., 2002; Scapigliati et 
al., 2002; Moore & Hawke, 2004). There is therefore great interest in developing 
immunological techniques and tools to elucidate the immune system of fish and 
establish methods for modulating the immune response of fish biology. Not only the 
health of fish under culture would benefit from studies of immune response, but also 
in general the knowledge gained will improve the understanding of vertebrates. Teleost 
are organisms that share characteristics with major vertebrates and as experimental 
organisms are easy to manage in practical terms, making fish good model organisms. 
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From a comparative immunology perspective, the work performed on this subject 
could contribute with information about fish that can be applied to major invertebrates 
(Trede et al., 2004). 
1.2 Understanding the teleost immune system 
Immunology is a complex subject continuously being enriched with new 
information. Experimentation in this field is frequently being redesigned based on 
these new findings, and new hypotheses to explain how the immune system functions 
in mammals, are presented and modified accordingly (Matzinger, 1994; Medzhitov & 
Janeway, 2000). Teleost immunologists have applied these novel results to fish 
immunology based on the evolutionary relationship between fish and mammals, but 
have done so with caution (Magor & Magor, 2001; Whyte, 2007),  and in general have 
focused on generating information by comparing analogous immune response 
mechanisms between fish and mammals (Dixon & Stet, 2001; Magor & Magor, 2001; 
Whyte, 2007). The immunological response is a complex interaction of mechanisms 
that have evolved in invertebrate and vertebrate organisms to preserve homeostasis. 
Some aspects of this defence system are triggered by the detection of foreign patterned 
molecules, or danger signals. The processes activated in response to these are divided, 
artificially, by researchers into innate (unspecific or natural) and adaptive (specific or 
acquired) (Table. 1.1). However, these are not separate events but a group of effectors 
interacting to communicate danger and defend according to the insult (Matzinger, 
1994; Dixon & Stet, 2001; Janeway & Medzhitov, 2002).  
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Table 1.1 Cells and molecules of the adaptative and innate arms of vertebrate immune 
systems (modified from Bayne & Gerwick, 2001, page 726). 
 
Chapter 2  
ADAPTIVE INNATE 
Tissues 
Lymphoid and 
mucosal 
Skin, liver, spleen, pronephros 
Cells T, B cells, APC 
B cells, NK cells, monocytes/macrophages, 
granulocytes 
Regulators Cytokines Cytokines/kemokines 
Humoral 
components 
Igs 
Complement system, clotting system, anti-proteases, 
metal-binding proteins, lectins, lysozymes, 
antimicrobial peptides, opsonins 
Kinetics Slow Fast 
 
The innate immune responses are preserved through evolution from invertebrates to 
vertebrates, with the gnathostomata being the first class to have developed not just 
innate mechanisms but also acquired mechanisms too. The immune responses of all 
jawed organisms show a highly conserved innate system, ability to rearrange genes for 
an adaptive immune function, and immunity with interacting unspecific and specific 
effectors. Through years of research it is known that the teleosts are capable of 
mounting immune responses (analogues and/or homologues) similar to mammals 
(with highly specialised adaptive immunity), however most of the processes are not 
well understood (Figure 1.1) (Dixon & Stet, 2001; Du Pasquier, 2001; Bowden et al., 
2005). 
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Figure 1.1 Innate and acquired immunity through the animal kingdom (based on Tort, 
Balasch & Mackenzie, 2003; Flajnik & Du Pasquier, 2004; Danilova, 2006). 
 
2.1.1 The innate immune response 
 
Invertebrate and vertebrate animals are born with a series of immune 
capabilities that enable them to react immediately against invading pathogens or other 
damaging processes. These inborn defences are the first line of attack, be it by 
anatomical, humoral or cellular means, and are characterised by protecting non-
specifically, i.e. recognising pathogens or signals of danger (pathogen and stress related 
molecules) with no differentiation between the source of danger.  
2.1.1.1     Enhancing the attack 
Physical barriers such as skin, scales, gastro-intestinal villi, and peristalsis are 
essential to hinder pathogen penetration as they offer a mechanical deterrent to the 
Invertebrates 
Vertebrates 
 
Innate immune response:                           
No specificity/No memory 
 
• Defence molecules 
• Complement systems  
• Pattern recognition receptors (TLR, PPR) 
• Phagocytic cells  
• Histocompatibility reaction 
Acquired immune response: 
Specificity/Memory 
• Lymphoid systems (spleen, thymus, bone marrow, 
mucosal tissues and germinal centres) 
• Histocompatibility receptors (MHC, MH, HLA) 
• Clonal expansion of cells  
• Somatic gene rearrangement mediated by RAG for 
Ig superfamily receptors 
• Ability to increase antibodies affinity after 
immunization 
• Increasing complexity of T and B-cell interactions  
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entry of invading microbes and toxins. These external tissues are covered with a 
glycoprotein containing a mucus layer that blocks the adherence of microorganisms by 
physically trapping them and preventing them from penetrating their host. In addition, 
mucus contains defence molecules such as lectins, pentraxins, lysozymes, anti-bacterial 
peptides, complement proteins, and natural antibodies that neutralise microbial 
enzymes, suppress growth or directly kill the microorganisms (Ellis, 2001; Saeij et al., 
2002).  If the micro-organisms overcome the external barriers then they must confront 
the humoral and cellular defensive mechanisms (both innate and adaptive) of the 
immune system. 
2.1.1.2     Detecting invasion 
According to Medzhitov & Janeway (1997), based on studies with mammals, the 
signals that are detected as a threat or danger are molecules intrinsic and physiologically 
necessary for the invading organisms to infect, but which are not made by the host 
organism themselves. These molecules are conserved between groups of related 
microbes; e.g. teichoic acid in Gram negative bacteria. These molecules are not 
recognised by receptors as a specific structure, but rather as a patterned molecule 
(pathogen-associated molecule pattern, PAMP). The response against the threat is 
initiated by the detection of PAMPs by proteins that are able to function as recognition 
receptors (pattern-recognition receptors, PRRs) and have broad specificity. Depending 
on the type, PRRs can be expressed externally (cell surface), internally (cytoplasm) or 
secreted (mucus, serum, etc) (Magnadottir, 2006). 
Another function is attributed to the recognition receptors (PRR’s) in mammals, 
and this is related to Anderson-Matzinger’s hypothesis (2000) by which PRRs also have 
the ability to detect self-molecules synthesised and/or released by stressed or injured 
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cells (heat shock proteins, double stranded DNA, etc). The release of self-molecules is a 
sign of danger that is encountered by the PRRs only when there is a cellular damage. It 
has been observed in fish toxicology studies, that heat shock proteins are up-regulated 
and the expression of cytokines is affected when organisms are exposed to high levels 
of contaminants, indicating possible immuno-modulation of the fish through these 
pathways (Eder et al., 2008). As stated by Wallin et al. (2002) and Dixon and Stet (2001), 
the detection of pathogen molecules or danger related self-molecules by PRRs possibly 
act in synchronicity (Figure 1.2), although such mechanisms already confirmed in 
mammals still need to be established in fish. 
2.1.1.3     Receptors of danger 
During the innate immune response, the molecules that recognise danger or 
non-self structures are mediators with specific tasks such as opsonisation, activation of 
complement, phagocytosis, etc. This arbitration work is performed by different PRR´s 
with affinities for a broad range of PAMP´s e.g. nucleic acids, proteins, carbohydrates, 
compound molecules (glycolipids, phospholipids, peptidoglucan, lipopolysaccharides, 
lipopeptides) (Lata & Raghava, 2008). Distinct classes of PRR’s are present in teleosts 
and every family has a function more and less conserved through evolution (Aoki et al., 
2008) (Table 1.2). Toll Like Receptors (TLRs) (Purcell et al., 2006), NOD Like 
Receptors (Laing et al., 2008) (NLRs), RIG-1 (retinoic acid-inducible gene)-Like 
proteins (RLRs) (Zou et al., 2009), C-type Lectin Receptors (CLRs), Mannan Binding 
Lectins (MBLs) (Russell & Lumsden, 2005), and complement receptors (Boshra & 
Sunyer, 2006) have all been described for teleosts (Table 1.2). In mammals, it is known 
that PAMPs are recognised by PPRs and these start a flow of events through different 
receptors that finally prime cells to release mediators (e.g. cytokines) (Kawai & Akira, 
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2009). Sepulcre et al. (2007) demonstrated that this could occur in teleosts by showing 
that macrophages and granulocytes, after being primed by PAMPs, released pro-
inflamatory cytokines.  The assemblage of the response, through these PRRs, provides 
the starting point of inflammation (Kawai & Akira, 2009). 
 
 
Figure 1.2 “Three models are shown that might explain how endogenous and/or 
microbial products activate professional antigen-presenting cells (pAPCs). (a) In 
the „extended self, non-self theory‟ proposed by Janeway, microbial products are 
recognized by pAPCs expressing pattern-recognition receptors (PRRs). (b) In the 
„danger theory‟ proposed by Matzinger, endogenous substances produced or 
released in response to tissue damage caused by microbes are recognized by pAPCs 
with receptors for endogenous danger signals (REDSs). (c) In a third model, there 
is the possibility of an overlap between these two models, such that stress-induced 
endogenous proteins form complexes with microbial products, and these 
complexes are recognized by pAPCs. Note that these models are not mutually 
exclusive. Abbreviations: HSP, heat-shock protein; LPS, lipopolysaccharide”. From 
(Wallin et al., 2002, page 133) 
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Table 1.2 Pattern-recognition receptors found in mammals and some identified in teleosts (from Aoki et al., 2008; page 266). 
 
 
  
2.1.1.4     Coordinating the acute phase response 
The unspecific (or non-specific) components of the immune system that 
provide a rapid reaction to aggression can be humoral or cellular. These components 
directly attend the site of the insult, but also provide instructions to initiate the 
adaptive immune system (Kawai & Akira, 2009). Physiological and metabolic changes 
take place when aggression is incurred to the organism; foreign or self molecules 
present at the wound site can stimulate secretion of pro-inflamatory cytokines, 
chemokines, and lipid mediators that initiate a group of processes called the acute 
phase response (APR) (Bayne & Gerwick, 2001).  
The initial phase during inflammation occurs by a rapid alteration of the 
homeostasis of the organisms. Humoral mediator molecules are secreted or released 
with the objective of modifying vascularisation, to facilitate the aggregation and 
activation of haematopoietic cells, eliminate the stimulus, clear away debris and restore 
normal structure and functions. Central nervous system, liver, and several populations 
of cells are stimulated to up-regulate or down-regulate secretion of proteins during 
APR. The secreted proteins that eventually increase (positive) or decrease (negative) 
with respect to normal plasmatic levels, are specific for the acute phase response and 
are called acute phase proteins (APP) (Bayne & Gerwick, 2001; Russell & Lumsden, 
2005). Cellular participation during APR is promoted by the release of mediators such 
as cytokines and chemokines, and is required to remove foreign particles or 
microorganisms and dead cells through phagocytosis (Afonso et al., 1998; Grayfer & 
Belosevic, 2009) (Figure 1.3).  
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Figure 1.3 “Diagram illustrating phenomena that induce an acute phase response in 
mammals, their immediate effects, and the mediators that are produced and that 
induce systemic reactions” (from Bayne & Gerwick, 2001 page 727). 
 
a) Soluble mediators 
Soluble factors called cytokines are the mediators of cell communication that 
act in a paracrine or autocrine manner in both the innate and the specific immune 
responses (Secombes et al., 1997). For humans, cytokines are a large family of proteins 
that can activate, inhibit or regulate immune function. Cytokines can be categorised 
into separate functions mainly during the innate response, the adaptive response or 
haematopoiesis, however it has been shown that there is no clear division in these 
categories (Kabelitz & Medzhitov, 2007). So far, the cytokines that intervene in the 
innate immune response of fish are similar to those described for humans. There are 
molecules described for interleukin (IL)-1beta, tumor necrosis factor alpha (TNF-
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alpha, interleukin 18 (IL-18) and chemokines such as IL-8 (Secombes et al., 2001; Zou 
et al., 2002), and MacKenzie et al. (2004) for instance, have found that TNF-alpha plays 
a similar role in the fish’s immune response to that seen in mammals. From the results 
of their experiments, they suggest that TNF-alpha is secreted by terminally 
differentiated macrophages, and that this cytokine has an important function as an 
activator of their phagocytic activity. However, while the activity of most cytokines is 
known in mammals, this information is still unclear for fish and dependent on the 
availability of recombinant peptides. 
b) APPs in teleosts 
The pentraxins, C-reactive protein-like (CRP), and serum amyloid P-like (SAP) 
proteins have been detected in several species of teleosts. Pentraxin-like proteins from 
fish have shown similar behaviour to those in mammals where an increase is detected 
during inflammation (positive APP). Just recently, genes from these pentraxin-like 
proteins were found to be up-regulated during infection by Yersinia ruckeri induced in 
O. mykiss (Raida & Buckman, 2009). These data, together with findings of agglutination 
and affinity to certain types of molecules from pathogens, suggest that CRP and SAP-
like proteins are important mediators of the immune response of fish as agglutinins 
and secreted PRRs (Bayne & Gerwick, 2001; Cook et al., 2003). 
The non pentraxin serum amyloid A (SAA) is a common protein in APR for 
vertebrates. However, different responses have been found in fish making it difficult to 
relate the SAA to the APR (Raida & Buchman, 2009; Villarroel et al., 2008). 
Transferrin is a glycoprotein that binds iron and can sequester it when 
environment levels are low; where bacteria find it difficult to survive at these low iron 
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levels. The level of transferrin in APR decreases in mammals, however, in contrast it 
has been found that in rainbow trout and catfish, levels of transferrin may increase 
during APR (Bayne & Gerwick, 2001, Peatman et al., 2007). 
The plasma protein α2-macroglobulin modulates the immune response by 
inhibiting or inactivating proteases. Peatman et al. (2007) found this molecule amongst 
the up regulated genes in catfish during infection. 
The complement system consists of 35 soluble and membrane bound proteins. 
Complement participates in the elimination of pathogens by creating pores in the 
membrane of the microbe or by facilitating phagocytosis through opsonisation of the 
microbe. Characteristically it produces an amplified response when triggered by a 
stimulus producing a cascade phenomenon. The complement cascade can be activated 
by three pathways: the classical pathway, which is stimulated by the binding of 
antibodies to the microbe membrane, acute phase proteins or directly by viruses, 
bacteria or infected cells. The alternative pathway is activated through contact with 
microorganisms independent of antibodies, and the lectin pathway is initiated by 
binding to a mannose-binding lectin. It is known that the main features of complement 
activation in fish occur in a similar manner to that of mammals, however, the 
mechanisms and molecules for some modes of activation are not clearly defined 
(Holland & Lambris, 2002; Boshra, Li & Sunyer, 2006). Some important components 
of the complement system have been identified as positive APP (Bayne & Gerwick, 
2001, Peatman et al., 2007). 
Lysozymes are enzymes that occur not only in mucus secretions, but also in 
plasma, peritoneal macrophages and blood neutrophils. Bacterial cell walls are attacked 
by lysozymes by cleaving peptidoglucans present in the bacterial cell call (Bayne & 
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Gerwick, 2001). These molecules have been the centre of various studies with an 
increase in the plasma concentration detected during inflammation (Magnadottir et al., 
2005; Mackenzie et al., 2008) 
c) Phagocytic cells  
The ability of granulocyte to phagocytose in vitro and in vivo has also been at the 
centre of many studies. Migration and phagocytic cellular activity have been observed 
during experimental inflammation in several fish species (Do Vale et al., 2002; Pressley 
et al., 2005; Serada et al., 2005; Chaves-Pozo et al., 2005; Cuesta et al., 2007 & 2008). The 
identification of cells involved early during inflammation has been difficult due to a 
lack of specific cell markers; even so, populations of phagocytic cells have been 
identified such as monocytes, macrophages, granulocytes, and more recently B-cells (Li 
et al., 2006; Overland et al., 2010). For instance Sepulcre et al. (2007) demonstrated that 
acidophilic granulocytes and macrophages express PRRs and are stimulated during 
inflammation, showing active phagocytosis (neutrophils) and/or release of cytokines. 
Another interesting observation was the phagocytic behaviour seen for B-cells of 
salmon, cod and trout indicating the participation of this population during the innate 
immune response (Li et al., 2006; Overland et al., 2010). Phagocytes have an important 
role in the defence mechanism of fish. These are cells that engulf microbes and kill 
them through the production of potent bactericidal substances. These products include 
reactive oxygen species (ROS) such as superoxide anion, H2O2 and the hydroxyl free 
radicals (OH+). In addition, macrophages can produce nitric oxide (NO) and 
subsequent peroxynitrites and hydroxyl ions (Ellis, 2001; Neuman et al., 2001). 
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2.1.2 Specific immunity  
The specific immune response provides strong protection against both 
extracellular and intracellular pathogens. These mechanisms are characterised by two 
important features: specificity and memory. The components of the specific or 
adaptive immune response include both humoral and cellular elements (Table 1.1). 
Specificity and memory are adaptations to the immune system that are obtained after 
the first encounter with the pathogen. 
As in mammals, macrophages and monocytes have the ability to present 
antigens to specialized cells for the initial propagation of the specific immune response 
(Vallejo et al., 1992, Sugamata et al., 2009). Specialised cells have been observed in fish, 
B cells responsible for antibody production (Manning & Nakanishi, 1997) and T cells 
that mediate cellular activity demonstrated both in vivo (Abelli et al., 1999) through graft 
recognition and in vitro (Meloni et al., 2006) by T cell proliferation during cytotoxity 
assays. Similarly molecules related with specific immunity have also been discovered in 
fish and these are mentioned later.  
Antibodies in fish are immunoglobulins (Ig) that consists of heavy (H) and light 
(L) chains with a tetrameric structure; it is usually referred to as IgM. Like mammals, 
fish have the ability to develop immunological memory, following the first encounter 
with the antigen; the B memory cells retain the ability to be re-stimulated by the 
antigen. A secondary antibody response in fish is faster and results in higher Ig titres in 
the serum, than the primary response (Kaattari & Piganelli, 1997, Manning & 
Nakanishi, 1997). B cells participate in the immune defence process through the 
production of humoral antibodies and T cells directly participating by specifically 
recognising pathogen peptides processed by exogenous and endogenous pathways. 
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Thymus derived cells or T cells, secrete a membrane heterodimer Ig-like 
molecule called the T-cell receptor (TcR) that is linked to the major histocompatibility 
complex (MHC) and CD3 complexes, and mediates the immune response towards the 
specific cellular recognition of antigens. The immunocompetent cell subpopulations 
can be differentiated by CD4 and CD8 markers. Helper T-cells (CD4+) participate by 
recognising exogenous antigens presented by the MHC II complex, releasing cytokines, 
and promoting the activation and maturation of cytotoxic T-cells and macrophages. 
Cytotoxic T-cells (CD8+) participate directly by destroying infected cells when it is 
ligated to the peptide-MHC I complex, and releasing cytokines (Roitt, 1997). For 
teleost so far, genes of the polymorphic (MHC) molecules class I and II have been 
cloned and sequenced in a number of fish species as well as T cell receptor (TcR) 
homologues (Rast & Litman 1994; Koppang et al., 2003; Dijikstra et al., 2001; 
Nakanishi et al., 2002; Dixon et al., 2003). Added to that, detection of RAG 
(recombination activating genes) has demonstrated that recombination activity in 
receptors of mature B and T cells of teleosts occurs (Wienholds et al., 2002; Huttenhuis 
et al., 2005). Furthermore, molecules such as CD4 and CD8 markers from specific immunity 
have been described allowing differentiation of helper and cytotoxic T cells in teleost 
(Picchietti et al., 2009; Shibasaki et al. 2010).  
2.1.3 Cellular activation 
In humans, cellular activation processes are initiated by signal to cell (e.g. 
cytokines-macrophage) or cell to cell interactions (e.g. TcR-APC) where particular 
membrane locations participate during cellular communication. At this leukocyte 
surface site where the interaction occurs a variety of receptors and ligands take part (e.g. 
TcR-MHC) depending on the identity of the participating cells (Moser 2003; Smith-
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Garvin, Koretzky & Jordan, 2009). So far, there has research in the ways in which this 
interaction occurs, even so many gaps that clarify the links between signalling 
molecules and cellular outcomes still exist. Activation occurs in several pathways where 
the initial triggering stimulates up/downregulation of participating proteins expression. 
Such proteins may be involved in signal transduction to change cell function, 
mediation to definite this function, and cytoskeletal rearrangement of a signalling zone 
to maintain or improve the cellular function (Smith-Garvin, Koretzky & Jordan, 2009, 
2009). For teleosts, cellular activation has been mostly studied in terms of the initial 
stimulus and final outcome of cell, but specific pathways and involved molecules are 
fairly well understood due the lack of tools for labelling cells (Burnet et al., 2000; Verjan 
et al., 2008). 
2.1.4 Markers 
In teleost immunology, mAbs recognising known surface molecules e.g the CD3 
marker for the TcR, or other molecules distinguishing between cell phenotypes or the 
functional state of T-cell populations, do not exist to nearly the same extend as those 
available for mammalian immunology (Table 1.3). Consequently, the existence of 
teleost cell subpopulations, such as CD4 and CD8 cells, has been deduced from 
indirect results and evidence of their functional activity (Iwama & Nakanishi, 1997; 
Partula, 1999; Romano et al., 2005). In 1999, Scapigliati et al. (page 14) stated that “few 
monoclonal antibodies (mAb) can be considered good T-cell markers”, and more than 
ten years later the situation is still nearly the same, although some results based on 
molecular approaches to developing markers have been added to the list of mAbs 
(Fisher et al., 2007). For human and murine cells, there are nearly 150 recognized 
membrane proteins to discriminate between cellular populations. Rombout et al. (1997) 
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found that from 469 clones obtained from one mouse immunised with membrane 
lysates (from carp Cyprinus carpio) only 18 detected thymocytes, and after the screening 
with flow cytometry just one (mAb WCL9) stained live thymocytes. However, this 
mAb developed against carp thymocytes reacted with a population of thymocytes (30-
50 %) and did not recognise peripheral blood cells. In another attempt to produce 
mAbs against T-cells, Rombout et al. (1998) found that one mAb out of 230 (WCL38) 
showed an affinity for intra- epithelial cells (IEL, apparently rich with T-cells), the 
source of the antigens utilised for immunising the mouse. This mAb (WCL38) 
recognised 50-70 % of the IEL and gill lymphoid population, less than 6 % and 3 % of 
cells from thymus and spleen respectively, and only a few cells in peripheral blood 
leukocytes (PBLs).  
Immunological studies to understand different immune processes in humans 
and mice have been greatly enhanced by the use of mAbs that recognise specific cell 
markers. The persistent lack of cell markers for teleosts has greatly hampered the 
development of more advanced immunological studies for teleosts; as these are 
especially important for understanding the dynamics of the fish immune system against 
infectious pathogens. This is quite a different situation from the knowledge acquired 
for human immunology, facilitated by over 150 markers used in the CD nomenclature 
to characterise epitopes of leukocytes (Fisher et al., 2007). 
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Table 1.3 Monoclonal antibodies developed against teleost leukocytes. 
Fish species Immunisation antigen Specificity Screening References 
Carp  
Cyprinus carpio 
Thymocytes  Other leukocytes  Secombes et al., 1983 
Thymocytes Early thymocytes ELISA, 
thymocytes, 
cytotoxic inhibition, 
FCM 
Yamaguchi et al., 1996 
Thymocyte plasma 
membranes  
Majority of leukocytes FCM, Leukocytes, , 
PHA enriched 
stimulated cells 
Rombout et al., 1997  
Intraepithelial leukocytes 
membranes 
Mucosal T-cells FCM Rombout et al., 1998 
 Thrombocytes  Nakayasu et al., 1998 
 Macrophages  Romano et al., 1997 
PBL Phagocytes  Nakayasu et al., 1997 
Catfish 
 Ictalurus punctatus 
Thymocytes and Ig-
negative PBL 
35 kDa antigen   Miller et al., 1987 
Thymocytes and 
peripheral T-cells 
Not T cell-specific FCM, mitogen 
stimulated 
lymphocytes 
Passer et al., 1996 
NK-like cells   Evans et al., 1988 
Thrombocytes    Passer et al., 1997 
Granulocytes   Bly et al., 1990 
   Ainsworth et al., 1990 
Sea bass  
Dicentrarchus labrax 
Thymocytes Fixed thymocytes, 
peripheral T-cells 
FCM, IIF,  Scapigliati et al., 1995 
Yellowtail  
Seriola 
quinqueradiata 
Thymocytes Majority of leukocytes  Nishimura et al., 1997 
    
Rainbow trout TcR DNA constructs Cross-reaction, non-T ELISA, FCM, Timmusk et al., 2003  
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Oncorhynchus 
mykiss 
Synthetic peptides, TcR 
sequence 
cells leukocytes, 
recombinant 
proteins 
Jansson et al., 2003 
    
Thymocytes, enriched Ig-
cells 
Thrombocytes ELISA, FCM, 
peptides, leukocytes 
Slierendrecht et al., 1995 
   Hill and Rowley 1998 
   Kollner et al., 2004 
 Granulocytes  Slierendrecht et al., 1995 
 Macrophages  Kuroda et al., 2000 
   Koellner et al., 2001 
Atlantic salmon 
Salmo salar 
 Granulocytes  Pettersen et al., 1995 
   Hamdani et al., 1998 
Hybrid catfish 
Pseudoplatystoma 
corruscans x P. 
fasciatum 
Thymocytes and 
thymocyte cytoplasmic 
membranes 
Lymphoid like cells ELISA, FCM, cells, 
FITC differential,  
Beelen et al., 2004 
Fugu 
Takifugu rubripes 
(polyclonal) cDNA  
fragment encoding fugu 
CD8α 
Lymphocytes, 
thrombocytes, and 
monocytes/macrophages 
Mitogen stimulated 
cells, FCM, 
Araki et al., 2008 
Several species B cells  IgM  Raison & Hidelman, 1984 
Estevez et al., 1994  
van der Heijen et al., 1995 
Scapigliati et al.,1996, 
Uchida et al., 2000 
 Stenvik et al., 2001 
Morrison et al., 2002  
Li et al., 2007  
Rathore et al., 2008  
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Compared with bovine, equine or swine species, research in fish immunology 
has experienced significant achievements in a relatively short time, partly because of 
the increasing importance of aquaculture as a source of food. There are now several 
successful vaccines and immunostimulants available to boost the fish immune system 
and increase the immunological processes to combat invading pathogens. However, 
for the majority, the mechanisms by which these enhance the immunity of fish are not 
very well understood due to limited knowledge about the fish immune system 
(Gudding, Lillehaug & Evensen, 1999). One of the main areas of interest is the 
detection, functional differentiation and organization of the cellular populations 
involved in the host response to infectious pathogens. In human and murine 
immunology, specific immunocompetent subpopulations have been identified as 
collaborators or direct executors of pathogen elimination by exogenous and 
endogenous pathways. However, for teleosts this distinctive functional participation 
has not been probed given a lack of mAbs to mark cellular subpopulations 
(Somamoto, Nakanishi, & Okamoto, 2002). Significant efforts in teleost immunology 
research have focused on the development of these markers, although these are few 
currently available. Such mAbs against the cells involved in the immune process would 
permit their detection, isolation, and/or discrimination to better develop and 
comprehend functional studies in vivo and in vitro.  
The present project, as a part of this effort to increase the number of fish cell 
markers, aimed to obtain a mAb to assist in the characterisation of thymus derived cell 
populations from rainbow trout (Oncorhynchus mykiss). 
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Aims of the study:  
The aim of the present study was to identify surface molecules associated with 
the phenotype of leukocytes that contributes to the understanding of teleost cellular 
function. This was investigated by using T-cell mitogen activation to up regulate the 
molecules that assist such a phenotype or functional differentiation of teleost cells, and 
to search possible methods that allow evaluation of the participation of surface 
molecules in cellular activation. 
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Chapter 3 Development of  Monoclonal Antibodies (mAbs) 
Against Thymic Cells of  Rainbow Trout 
3.1 Introduction 
A great deal of effort has been made to generate mAbs against surface epitopes 
for differentiation between leukocyte populations of teleost immune cells. A variety of 
approaches have been used by researchers to develop mAbs against these cells. 
However, attempts to make these mAbs have been hampered by the high inter and 
intra-specific genetic heterogeneity between fish (Miller et al., 2001). Over 28 
publications have been produced focusing on the development of specific markers for 
immunocompetent cells and components of the immune response of fish (not 
including IgM´s from B-cells), based on traditional mAb technology (Table 1.3, 
Chapter 1). However, only a few of these have provided convincing evidence that 
specific populations of cells are recognised by these mAbs (Randelli et al., 2008). The 
few reports of markers raised against teleost thymocytes include mAb DLT15 (Sea 
Bass, Dicentrarchus labrax) (Scapigliati et al., 1995), CfT1 (channel catfish, Ictalurus 
punctatus) (Passer et al., 1996), WCL9 (Carp, Cyprinus carpio) (Rombout et al., 1997), and 
PST 33 (hybrid surubim catfish, Pseudoplatystoma corruscans x P. fasciatum) (Beelen et al., 
2004). 
A number of points need to be considered regarding the methodology used to 
develop mAbs suitable for identifying cell markers in fish. Of particular note are the 
immunisation and screening protocols used to produce the mAbs. The type of antigens 
used for immunising mice varies greatly between studies from simple to complex 
preparations of cells. Whole thymic cells (Secombes et al., 1983; Yamaguchi et al., 1996; 
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Nishimura et al., 1995), thymocyte plasma membranes (Rombout et al., 1997), and 
thymocytes enriched with Ig-ve cells isolated from peripheral blood leukocytes (PBLs) 
(Passer, 1996) have all been used to immunise mice. Effort has been made to maintain 
the antigenic repertoire of these cell preparations in their native form (i.e. by using 
unfixed cells). These preparations generally include the isolation, and enrichment of 
leukocytes, and lysing with mild detergents (e.g. Passer et al. 1996). Inactive cells, cell 
membranes and/or lysates are then mixed with adjuvants to enhance the immune 
response of the mouse to the antigens. Scapigliati et al. (1995), however, used a 
preparation of whole thymocytes fixed with 2 % para-formaldehyde, mixed with 
adjuvant, to immunise the mouse. The process of fixing the cells may have denatured 
immunogenic antigens on the cells, however these researchers did successfully develop 
a mAb from their fusion that was able to recognise a T-cell population in Sea Sass, 
using either live or fixed cells (i.e. mAb DLT15). More recently, advances in genetic 
technology have been employed to immunise mice. DNA constructs containing the 
gene for the α chain of the TcR have been used to vaccinate mice (Timmusk et al., 
2003), while synthetic peptides prepared for the α and β chain gene sequences of the 
TcR were used by Jansson et al., (2003). The aim of their studies was to immunise the 
mice with specific antigens in the hope of producing antibodies against the TcR 
portion on the T-cell. However, given the divergence of the gene for TcR found in 
mammals (Jansson et al., 2003), the antibodies produced in these studies were not 
specific for the TcR of teleost.  
It has been shown through years of producing mAbs against mammalian 
leukocytes that the specificity and applicability of the mAbs produced depends greatly 
on the methodology used to screen and select the mAbs during their production 
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(Vollmers et al., 1998). A diverse range of immunological assays have been used to 
screen the mAbs produced against fish thymocytes (Scapigliati, Romano & Abelli, 
1999; Randelli, Buonocore & Scapigliati, 2008). For example, enzyme linked 
immunosorbent assay (ELISA), indirect immunofluorescence (IIF), flow cytometry 
(FCM), immunohistochemistry (IHC) and mitogenic simulation have all been used in 
the selection of potential hybridomas and to help in their subsequent characterisation.  
The use of ELISA for the initial screening of the fusion allows a large number 
of samples to be tested. Lysates, recombinant proteins and peptides, used to immunise 
the mice, have then been used to coat ELISA plates for screening the fusion 
(Yamaguchi et al., 1996; Jansson et al., 2003; Timmusk et al., 2003). Other methods, 
such as IHC and IIF, are particularly useful for characterising mAbs of interest. The 
basis of these methods is staining of cells so they can be visualised by microscopy or 
FCM, and they are thus helpful in the identification and characterisation of mAbs 
which recognised specific cell population and thus potential cell markers. By using 
these methods, it is possible to examine the distribution and levels of positively stained 
cells within different tissues. These are particularly useful in immunologically rich 
tissues such as peripheral blood, thymus, spleen, gut, epithelia, head kidney, gill, or skin 
where there is a source of leukocytes. For instance, Scapigliati et al. (1995) selected 
mAb DLT15 as a T-cell marker because it was able to stain living cells in FCM and 
also in fixed tissue sections by IHC. The results obtained by FCM clearly showed that 
thymocytes were specifically stained by mAb DLT15. Further characterisation of this 
mAb confirmed it’s specificity for sea bass T-cells (Abelli et al., 1999; Scapigliati et al., 
2000).  
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After screening by FCM, Passer et al. (1996) selected mAb CfT1 from its 
immunostaining pattern with catfish cells stimulated with mitogens against T or B-
cells. They found an increase in staining by mAb CfT1+ with cells stimulated with the 
T-cell mitogen, Concavalin A (Con A). In contrast, a decrease in the numbers of 
positively stained cells stimulated with the B-cell stimulator Lipopolysaccharide (LPS). 
So far, it has been possible to differentiate between four different leukocyte 
populations for rainbow trout using mAbs, i.e. B cells (Sanchez, et al. 1995), 
thrombocytes (Slierendrecht et al., 1995; Hill & Rowley, 1998; Koellner, 2004) 
granulocytes (Slierendrecht et al., 1995), and macrophages (Kuroda, Okamoto & 
Fukuda, 2000; Koellner, 2001). Although convincing results have been obtained using 
these markers, the exact identity of the epitopes labelled with the mAbs is still 
unknown; except for Igs on B cells (see Chapter 1). Meloni et al. (2006) were able to 
examine the role of T-cells activated by non-histocompatible recognition during a 
mixed leukocyte reactions (MLR) for sea bass using one of the mAbs they developed 
against T-cells. Most of the studies developing mAbs against fish leukocytes have used 
antigens either present on cells (i.e. whole cell preparations) or as molecules purified 
from unstimulated cells (i.e. using cells under static cellular conditions). Given the fact 
that the molecules were isolated, synthesised, or present on unstimulated cells, they do 
not necessarily reflect dynamic cellular function. An alternative strategy for developing 
mAbs against teleost thymocytes is presented in the current chapter, which was to 
screen hybridoma supernatants with cells in a dynamic state i.e. responding to a 
stimulus. This approach was used in an attempt to produce mAbs against functional 
cell surface antigens. It was thought that an assay that promotes T-cell functional 
display by detection of foreign MHC could be used to detect mAbs which reacted with 
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T-cell populations by FCM. The MLR is a commonly used method to evaluate the 
allogenic activation of immunocompetent cells in vitro against incompatible MHC 
molecules in graft studies (see Figure 2.1) (Sprent, 1998; Mak & Saunders, 2006). 
During a MLR, TcR on CD4+ cells respond with an intense activation that induces 
proliferation and liberation of mediators via cross-linking with non-self MHC-II. 
Additionally, CD8+ cells respond and are activated by directly recognising MHC-I in 
foreign cells by means of the TcR (Roitt, 1997). 
An assay in which mixed allogenic PBLs are used in order to promote a 
leukocyte reaction has been employed by researchers to hypothesise the existence of T-
cell subpopulations. This type of assay has allowed researchers to establish that CD8+ 
and CD4+ -like functions are present in teleosts, where the cells are capable of being 
activated, and respond to non-self molecules and undergo cellular proliferation (Miller 
et al., 1987; Abelli et al., 1999; Meloni et al., 2006; Utke et al., 2007; Araki et al., 2008; 
Moulana et al., 2008). In the present study, a histocompatibility reaction (or activation 
via foreign histocompatibility complexes, HCA) was chosen as a suitable test to help 
select positive hybridomas by detecting activated T-cells. It is known that there is a 
high degree of variability between individual fish in the ability of their cells to respond 
in vitro against allogeneic molecules or unkwon major histocompatibility complexes 
(Meloni et al., 2006). It was therefore thought that to ensure the presence of responsive 
cells from at least one fish in the reaction, the PBLs from more than two fish should 
be mixed together. It was considered that the response of fish to the leukocytes of 
more than one fish in this multiple reaction would improve the overall numbers of 
CD4+ and CD8+ T-cells obtained for screening the hybridoma supernatants.  
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A modification was made to this multiple way HCA (mHCA). Mitogens were 
added to the reaction to enhance the “basal” activation of T-cells during the mHCA. 
The mitogen Con A, a lectin that promotes activation and proliferation of human T-
cells (Sharon & Lis, 2004; Stone et al., 2009) was added to the mHCA to “enhance” the 
basal levels of activation of the T-cell population already reacting in the mHCA. It was 
thought that this would help in the selection of hybridomas able to detect differences 
in the activated cells reacting in the mHCA, stimulated with the mitogen. 
 
 
Figure 3.1 Mixed Lymphocyte Reaction (MLR). Example: screening of donor 1 and 
donor 2 for suitability as tissue in graft transplant. The donor “stimulator” PBLs are 
isolated and irradiated (jagged arrow), further the PBLs from the “responders”are 
mixed with recipients PBL. (A) T cells from the recipient are activated by 
allorecognition of MHC from donor 1 cells and incorporate [ 3 H]-thymidine into 
their DNA as they proliferate (high radioactivity). (B) The recipient T cells are not 
activated by donor 2 cells so there is minimal proliferation and incorporation of 3H-
thymidine corresponding to a MHC matching. (From Mak & Saunders, 2006, page 
893). 
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A method used to evaluate the histocompatibility is to assess the level of 
proliferation, detected by the incorporation of [ 3 H]-thymidine into the DNA of 
proliferating cells (Figure 2.1) However an alternative to this method can be FCM 
analysis to assess cell activation and proliferation, but relies on mAbs that react with 
cell markers for T-cells to do so. In an attempt to visualise differences on the detection 
ability of preliminary selected hybridomas after the cloning procedure, a final screening 
using FCM and stimulated cells was used. 
 
Aim: 
The aim of this Chapter was to generate antibodies against activated T-cell 
populations of rainbow trout obtained by immunising mice with whole thymocytes 
isolated from the thymus of rainbow trout. Positive hybridomas were initially selected 
by their ability to detect surface epitopes on thymic cells by Dot blot. A subsequent 
screening was performed by FCM to identify clones able to detect cells with 
lymphocyte characteristics in whole blood. Finally, the positive clones were assessed to 
determine their ability to show differences in labelled cells during mHCA assays using 
FCM.  
3.2 Material and Methods 
3.2.1 Isolation of leukocytes from rainbow trout 
Rainbow trout, O. mykiss, obtained from Buckieburn Fish Farm, Stirlingshire, 
UK (56° 2'33"N 4° 0'25"O), were maintained in tanks at ambient temperature with 
flow-through water at the Aquatic Research Facility, University of Stirling, Stirling, 
 29 
 
UK. Fish weighing between 0.2 - 0.4 kg were fed commercial dried trout pellets daily 
to satiation. The fish were killed with an overdose of benzocaine 10 % w/v in ethanol 
(Sigma Aldrich, Dorset, UK). 
Leukocytes were isolated following the procedure of Scharsack et al. (2001) 
unless otherwise stated. Medium RPMI 1640 (Sigma Aldrich) used to isolate the cells 
was prepared by diluting with 10 % distilled water to adjust the osmolarity of the 
medium. Heparin was added to the medium at 50 units ml-1 (Sigma Aldrich) and the 
isolation procedure was performed either on ice or at 4oC. 
3.2.1.1     Peripheral blood leukocytes (PBLs) 
Five ml syringes were prefilled with 2 ml of RPMI medium, diluted as described 
above. Blood was withdrawn from the caudal vein into the prefilled syringe and 
centrifuged at 90 x g for 5 min then 400 x g for a further 10 min. The buffy coat of 
leukocytes was collected, layered onto 5 ml Ficoll Histopaque 1.077 (Sigma Aldrich) 
and centrifuged at 750 g during 30 min at 4oC. The PBL´s were recovered from the 
Histopaque layer and washed with phosphate buffered saline (PBS; 0.02 M phosphate, 
0.15 M NaCl, pH 7.2 adjusted with HCl) at 1000 x g for 10 min. 
3.2.1.2     Tissue leukocytes 
Thymus and spleen were removed from fish, and teased through a cell strainer 
consisting of a 100 µm mesh (BD Biosciences, Oxford, UK), into a 5 ml Petri dish 
containing diluted RPMI medium. The final volume of the cell suspension was 
approximately 3 ml which was layered onto 5 ml of Ficoll Histopaque 1.077 and 
centrifuged at 4oC in a swing-out rotor 30 min at 800 x g. The thymic leukocytes (TL’s) 
were recovered from the interface and washed twice with diluted medium by 
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centrifuging for 10 min at 1000 x g (Scharsack, 2001). The procedure was performed 
on ice whenever possible.  
3.2.2 Thymic leukocyte activation 
Culture medium was prepared according to Scharsack, (2001). For this, diluted 
RPMI 1640 was supplemented with 105 IU L-1 of penicillin, 100 mg L-1 of 
streptomycin, 4 mM L-glutamine, 15 mM HEPES buffer, 25 µM 2-mercaptoethanol 
(all from Sigma Aldrich) and 5 % rainbow trout plasma. The plasma used was a pool of 
plasma from six individual fish that had been heat inactivated at 56°C for 30 min. This 
was then filter sterilised using a 0.22 µm filter (BD Biosciences) and frozen until used. 
The TL’s were activated by culturing them at a concentration of 1 x107 cells ml-1 
for 3 days in RPMI culture medium as described and supplemented with 30 µg ml-1 
Concanavalin A (Con A, from Canavalia ensiformis, type IV-S) (Sigma Aldrich.) in sterile 
6 well plates (Nunclon, Fisher Scientific, Leicestershire UK). Activated cells were 
recovered and washed with PBS by centrifuging for 10 min at 1000 x g. 
3.2.3 Monoclonal antibody production 
One BALB/c mouse was immunised with an intraperitoneal injection of 0.1 ml 
PBS containing 1 x107 non-activated thymocytes (M1) and another mouse was 
immunised with activated thymocytes (M1CA) emulsified 1:1 with Titermax Gold (Cyt 
Rx Corporation, Stratech, Cambridgeshire, UK). Mice were boosted 6 weeks later with 
non-activated or activated thymocytes as before. Four days before harvesting the 
spleen thymocytes for the fusion, mice were finally boosted intravenously with non-
activated or activated thymocytes through the tail vein. 
5 x 10
4
 cells 
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3.2.3.1     Generation of monoclonal antibodies 
Mice were sacrificed by CO2 asphyxiation. The spleen from mouse M1CA was 
removed and passed through a cell strainer. The cells were collected and washed with 
DMEM containing additives (Sigma Aldrich) at 85 x g for 7 min. The pellet was 
recovered and mixed 1:1 with SP2 myeloma cells (Sigma Aldrich) before fusing the 
cells using polyethylene glycol (Sigma Aldrich). The fused cells were seeded into 96 
wells plates using mouse red blood cells as a feeder layer with DMEM medium (Sigma 
Aldrich) supplemented with 20 % foetal calf serum (FCS) (Sigma Aldrich), and 2 % 
hypoxanthine-aminopterine-thymidine (HAT). The hybridoma supernatants from the 
first, second and third cloning were tested for the presence of antibodies to thymus 
leukocytes by Dot blot analysis as described in Section 2.2.3.2. Once cloned by the 
limiting dilution method (Campbell, 1984), the positive clones were re-screened by 
flow cytometry (FCM). The positive hybridomas from the Dot blot were first probed 
to determine their ability to detect cells in the lymphocyte region of whole peripheral 
blood. Hybridoma supernatants detecting cells in the R1 region were evaluated by 
FCM with cells from the mHCA as is shown in Figure 2.2.  
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Figure 3.2 Diagram showing the process used for screening the hybridomas. PB, 
peripheral blood; bmHCA, basal multiple way histocompatibility activation; 
emHCA, enhanced multiple way histocompatibility activation. 
 
3.2.3.2     Dot blot optimisation and selection of monoclonal antibodies 
Hybond-ECL nitrocellulose membrane (GE Healthcare, Chalfont, UK) was 
pre-wet with Tris buffered saline (TBS: 20mM Tris-HCl, 500mM NaCl, pH 7.5) and 
placed in the Bio-Dot Microfiltration Apparatus (BioRad, CA, USA). Thymic and 
spleen cells were isolated as described in Section 2.2.1.2, and added to sample wells of 
the Dot blot at a concentration of 5 x104 or 1 x105 cells in 50 μl of Foetal Calf Serum 
solution (1% FCS in TTBS: TBS containing 0.05% Tween 20). The wells containing 
cells were drained and the cells were trapped onto the membrane, after which 200 μl of 
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blocking solution containing FCS (1% FCS in TBS) was added to each well for 
approximately 60 min before draining the well by gravity. The wells were then washed 
twice with 300 μl of TTBS by applying a vacuum to the membrane. Test bleeds from 
the two mice, one immunised with non activated cells (M1) and the other with 
activated cells (M1CA) were evaluated by diluting the serum 1:100 with antibody 
buffer, (TTBS with 1%BSA) and 100 μl of diluted serum or hybridoma supernatant 
was added to each sample well and allowed to filter into the membrane by gravity as 
before. For the negative control, HT culture medium was used instead of cells. Wells 
were washed three times with TTBS before adding 100 μl of the secondary antibody i.e. 
anti-mouse IgG-Horseradish peroxidase (HRP) (Sigma Aldrich) diluted 1:100 in 
antibody buffer and filtered though the membrane by gravity. The wells were washed 
twice with 300 μl of TTBS and twice with TBS to remove excess Tween. The assay 
was developed by adding 100 μl of 4 CN peroxidase substrate (KPL, USA) to each 
well. Once the colour development was complete, the reaction was stopped by washing 
the membrane with 200 μl of distilled water. The Dot blot colour development was 
evaluated visually. 
3.2.4 Cytometry screening 
3.2.4.1     PBLs isolation 
In order to obtain sufficient numbers of cells for hybridomes screening with 
FCM, PBL´s were isolated. For the first screening by FCM, whole peripheral blood 
was collected from the caudal vein of an anesthetised fish, as previously described in 
Section 2.2.1, using a 5 ml heparinised syringe. Whole blood from individual fish was 
then prepared for FCM analysis. The hybridoma supernatants which reacted with cells 
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localized in the LL region, a zone expected to contain mainly lymphocytes and 
thrombocytes, were selected (Scharsack et al., 2001).  
 
When using cells from the HCA to screen clones from the second cloning by 
FCM, peripheral blood leukocytes were isolated according to Scharsack (2001) with 
modifications. Anesthetised fish were bled by caudal venipuncture with a 5 ml syringe 
containing 2 ml of diluted heparinised RPMI 1640 medium. Samples were maintained 
on ice whenever possible. Diluted heparinised blood was first centrifuged for 5 min at 
90 x g and then subsequently 10 min at 400 x g in polystyrene tubes. The layer 
containing the leukocytes was separated from the erythrocytes and diluted with 2 ml of 
diluted RPMI medium. Subsequently, the suspension was layered onto 3 ml of 
Histopaque 1077, and centrifuged for 45 min at 900 x g. The PBL’s were then 
recovered from the density gradient and washed with diluted medium for 10 min at 
1000 x g. Pellets from five different fish were pooled in cell culture medium. Numbers 
of cells were counted using a haemocytometer, and adjusted to 4 x107 cells ml-1 with 
cell culture medium.  
3.2.4.2     Multiple way histocompatibility activation (mHCA) 
The PBL’s from 5 fish were pooled using 1 x107 from each fish. The pooled cell 
suspension was plated into a 96 well flat bottom plate at a density of 1 x106 cells per 
well in 175 μl cell culture medium. Two different sets of wells containing the pooled 
leukocytes from the 5 fish were prepared in a mHCA assay by triplicate: one set of 
wells contained a “basal multiple way Histocompatibility Activation” (bmHCA) (i.e. 
control wells), to which was added 25 μl of cell culture medium without Con A to 
make the volume up to 200 μl per well.  The other set of wells contained an “enhanced 
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multiple way Histocompatibility Activation” (emHCA) with Con A. This was prepared 
by adding 25 μl of culture medium containing Con A to obtain a final concentration of 
30 μg Con A ml-1 per well (Figure 2.3). Plates were incubated for 6 days at 15°C in an 
atmosphere with 100 % relative humidity and 3 % CO2. Following this, cells were 
recovered for analysis by FCM. 
 
 
 
 
Figure 3.3 Diagram showing mHCA assay preparation. bmHCA, basal multiple way 
histocompatibility activation; emHCA, enhanced multiple way histocompatibility 
activation. 
 
3.2.4.3     IIF staining for first screening by FCM  
Fifty µl of complete peripheral blood were incubated with 180 µl of hybridoma 
supernatant for 30 min. Cells were kept on ice with frequent shaking. Two ml of 
PBS/BSA was added to each tube and washed as described above. The cells were 
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resuspended in 200 μl of secondary antibody (rabbit anti-mouse FITC conjugate 
diluted 1:50 with PBS with 1 % bovine serum albumin (BSA), Vector). Samples were 
kept on ice in the dark for 30 min with frequent shaking. The cells were washed with 2 
ml PBS/BSA. Cell pellets were resuspended by vortexing with 1 ml of FACS buffer 
(BD Biosciences), stored on ice in the dark and analysed by FCM as soon as possible 
thereafter. Background controls were prepared by adding FITC conjugate secondary 
antibody to cells without the first antibody.  For the negative control neither the first 
nor secondary antibodies were added. Positive controls to determine the intensity level 
of fluorescence were prepared by staining cells from mHCA with polyclonal antibodies 
(M1CA) as the first antibody then the FITC-conjugate as the secondary antibody. 
3.2.4.4     Multiple way histocompatibility activation (mHCA) screening by 
flow cytometry (FCM) 
After 5 days, cells from the HCA were resuspended using plastic tips with bored 
ends (cut with sterile scalpel) to avoid cell damage and transferred to polystyrene tubes 
(Falcon). For every positive hybridoma selected by Dot blot, two tubes containing cells 
from bmHCA and two with emHCA cells were prepared (the contents of one well 
tube-1). The cells were washed with PBS containing 0.5 % BSA and 0.05 % sodium 
azide (PBS/BSA) for 10 min at 1000 x g. Afterwards, indirect immuno-fluorescence 
staining was performed by incubating the isolated cells in 200 μl of hybridoma 
supernatant for 30 min, then following the procedure described in Section 2.2.4.3. 
3.2.4.5     Flow cytometry (FCM) 
Forward scattered light (FSC), side scattered light (SSC) and fluorescence 
intensity were registered for 5,000 or 10,000 events without gating using a flow 
cytometer with an argon laser at 488 nm (FACScan®, Becton Dickinson, Germany). 
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Data were analysed with the WinMIDI program (version 2.9) which provided 
histograms for fluorescence illustrating intensity on a logarithmic scale. The data were 
acquired in a 1024 channel scale producing a dot plot that represented a nominal range 
of four decades of intensity (as presented in histograms) and adjusted by calibrating 
with Calibrite beads (BD Biosciences). The flow cytometer settings were adjusted and 
saved for every batch of experiments. During acquisition, to analyse the various sets of 
experiments, the saved settings were retrieved and maintained. Statistical means and 
the standard deviations were calculated for the positive hybridoma supernatants to 
compare the proportions of labelled cells between the sets of HCA´s, and a one way 
ANOVA analysis was performed. 
 
3.3 Results 
3.3.1 Dot blot optimisation and selection of monoclonal antibodies  
Polyclonal sera from immunised mice (M1 and M1CA) were used to optimise 
the Dot blot assay (Figure 2.4). Although both polyclonal antibodies had a good 
response in the assay, only one mouse was actually used for the fusion due to the 
impracticality of managing large numbers of clones at the same time using Dot blot 
and IIF to perform the screening. Two different cell concentrations were evaluated for 
the Dot blot, i.e. 5 x104 and 1 x105cells. A strong reaction was obtained with the fewest 
number of cells (5 x 104) and this cell concentration was therefore employed for 
subsequent assays. This was so that there were sufficient numbers of TL’s to perform 
the screening of the hybridomas. Differences in the level of staining obtained between 
thymocytes and splenocytes with the polyclonal antibody (pAb) were small, but more 
stain was present with the thymic cells than the spleen cells. The M1CA mouse was 
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used for the fusion and a concentration of 5 x104 of thymic leukocytes was used to 
screen the hybridomas, as shown in Figure 2.4. 
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Figure 3.4 Optimisation of Dot blot screening. Samples were used in duplicate. Concentration 1, C1 and Concentration 2, C2. 
 40 
 
3.3.2 Screening the fusion by Dot blot 
A total of 564 hybridomas were screened from the fusion, 41 were selected for 
the first cloning, based on the strength of staining obtained in the Dot blot against 
TL’s (Figure 2.5). By the end of the 3rd cloning 24 clones were selected for further 
screening by FCM. 
 
 
Figure 3.5 Screening hybridomas by Dot blot against thymus leukocytes. Square 
indicates colour intensity of positive clones. 
3.3.3 Screening by flow cytometry (FCM) 
Twenty four clones were screened by FCM using whole peripheral blood. 
Eighteen of these gave insufficient staining within the lymphocyte region and no 
further characterization of these was carried out. The four remaining hybridomas, 
TcOm14, TcOm15, TcOm34 and TcOm36, were further evaluated due to their ability 
to detect cells in the lymphoid region of the FCM dot plot (Figures 2.6- 2.11). The 
immunoglobulin isotyping indicated that the four hybridomes remaining belonged to 
the subclass IgG1. 
These 4 clones were screened by FCM to evaluate their ability to detect 
differences in numbers of cells within the R1 population using cells from an emHCA 
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and a bmHCA. The mAb TcOm15 was considered a potential marker since reacted 
with cells gated in the R1 region, the population considered as lymphocytes. This mAb 
also gave more defined staining of medium size cells with low cytoplasmic internal 
complexity mainly within region R1. Forward side scatter or the relative size of the 
cells was from 200 to 450 while SSC or relative granularity was from 40 to 125 (Figure 
2.7). From 3 replicate samples, mAb TcOm15 detected an increase of about 1.68 times 
of labelled cells in emHCA population compared with cells from the bmHCA (Table 
2.1 & Figure 2.7 c). It also detected a significantly greater percentage of total labelled 
cells in the enhanced reaction compared with the basal mHCA (p value ANOVA= 
0.024). When proportions of fluorescing cells in the R1 region were compared with 
respect to the total population, a twofold increased in the proportion of labelled cells 
was observed (Table 2.1 & Figure 2.7 d). There was a significant increase in the 
number of cells detected by mAb TcOm15 within the gated region of R1 in the 
enhanced mHCA compared with the basal mHCA (p value ANOVA= 0.004). This 
mAb was potentially positive for cells apparently undergoing activation. 
From the remaining three clones evaluated by FCM, mAbs TcOm14 and 
TcOm36 were discarded as possible cell markers because they showed a high level of 
staining of cells outside R1, (Figure 2.8 & Figure 2.9). MAb TcOm34 detected an 
increase number of cells in the emHCA cell population compared to the bmHCA cells 
(Figure 2.10). However, the staining with this mAb was considered non-specific 
because of the irregular pattern of detection of cells outside the R1 region. 
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Figure 3.6 Pattern of cells detected in FCM from mHCA assays with no antibody staining. I) FSC/SSC dot plots and FSC/FL1 histograms 
of cells prepared for background control. II) Cells prepared for negative control. (a) percentage of fluorescing cells from total events; 
mark 1 (M1), indicates percentage of cells in the positive fluorescence intensity value (b) FSC/fluorescence of labelled cells from the 
total counted cell; (c) Gate R1; and (d) percentage of fluorescing cells from gate R1 in mark 2 (M2). Green dots, fluorescing cells. 
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Figure 3.7 Pattern of cells detected by FCM stained with mAb TcOm15. I) FSC/SSC dot plots and FSC/FL1 histograms of cells from the 
basal mHCA. II) Cells from the enhanced mHCA. (a) percentage of fluorescing cells from total events; mark 1 (M1), indicates 
percentage of cells in the positive fluorescence intensity value (b) FSC/fluorescence of labelled cells from the total counted cell; (c) 
Gate R1; and (d) percentage of fluorescing cells from gate R1 in mark 2 (M2). Green dots, fluorescing cells. Minus background, a) and d). 
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Figure 3.8 Pattern of cells detected by FCM stained with mAb TcOm14. I) FSC/SSC dot plots and FSC/FL1 histograms of cells from the 
basal mHCA. II) Cells from the enhanced mHCA. (a) percentage of fluorescing cells from total events; mark 1 (M1), indicates 
percentage of cells in the positive fluorescence intensity value (b) FSC/fluorescence of labelled cells from the total counted cell; (c) 
Gate R1; and (d) percentage of fluorescing cells from gate R1 in mark 2 (M2). Green dots, fluorescing cells. Minus background, a) and d). 
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Figure 3.9 Pattern of cells detected by FCM stained with mAb TcOm36. I) FSC/SSC dot plots and FSC/FL1 histograms of cells from the 
basal mHCA. II) Cells from the enhanced mHCA. (a) percentage of fluorescing cells from total events; mark 1 (M1), indicates 
percentage of cells in the positive fluorescence intensity value (b) FSC/fluorescence of labelled cells from the total counted cell; (c) 
Gate R1; and (d) percentage of fluorescing cells from gate R1 in mark 2 (M2). Green dots, fluorescing cells. Minus background, a) and d). 
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Figure 3.10 Pattern of cells detected by FCM stained with mAb TcOm34. I) FSC/SSC dot plots and FSC/FL1 histograms of cells from the 
basal mHCA. II) Cells from the enhanced mHCA. (a) percentage of fluorescing cells from total events; mark 1 (M1), indicates 
percentage of cells in the positive fluorescence intensity value (b) FSC/fluorescence of labelled cells from the total counted cell; (c) 
Gate R1; and (d) percentage of fluorescing cells from gate R1 in mark 2 (M2). Green dots, fluorescing cells. Minus background, a) and d). 
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Table 3.1 Proportions of rainbow trout blood leukocytes from mHCA assays labelled with mAb TcOm15 by IIF evaluated by 
flow cytometry. Background was subtracted. 
 
Replicate ID # Events 
Culture 
days 
% TOTAL 
fluorescing cells 
Detected 
increase 
E/B= 
% GATED 
fluorescing cells in 
R1 
Detected 
increase 
E/B= 
Basal Reaction 
15bmHCAc 10000 5 5.5  2.7  
15bmHCAd 10000 5 7.2  5.0  
15bmHCA2 5000 7 8.2  3.5  
  ± s.d. 7.0 ± 1.2  3.7 ± 1.2  
Enhanced Reaction 
15emHCAa 10000 5 11.4  7.8  
15emHCAb 10000 5 10.2  8.3  
15emHCA1 5000 7 14.1  9.4  
  ± s.d. 11.9 ± 2.0* 1.7 8.5 ± 0.8* 2.2 
B=basal mHCA, E=enhanced mHCA 
*P  <0.024 for Total B vs E 
*P <0.004 for Gated R1 B vs E 
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3.4 Discussion  
Immunization of a mouse with Con A-stimulated thymic cells (M1CA) resulted 
in the production of pAbs that reacted with whole thymic cells. The underlying 
principle of using the M1CA mouse for the fusion was based on the possibility that the 
lectin promoted the activation of the target T-cell population (Manning & Nakanishi, 
1997). In humans, this mitogen is capable of binding to membrane glycoproteins from 
different clones of T-cells initiating transduction signals, activation, expression of 
molecules, and finally proliferation (Roitt, 1997; Jason & Inge, 2000).  It was expected 
therefore that pAbs produced by the M1CA mouse would have a higher reaction 
against thymic cells than that of the M1 mouse (immunised with non-stimulated 
thymocytes). However, when pAbs from the M1 and M1CA mice were compared for 
immunorectivity against whole thymic and spleenic cells no obvious difference was 
seen between their reactivity. This apparently similar antibody response was based on 
the results of the Dot blot and does not mean that the epitopes recognised by the 
antibodies were the same. Also the titres of the sera from these two mice were not 
measured, so possibly there may have been differences in the levels of reacting Ab 
between the two sera. The strength of staining obtained with the pAb was related to 
the amount of cells used in the Dot blot assay, implying a proportional reduction or 
increase of recognised epitopes. As the pAbs recognised surface epitopes on both 
thymocytes and splenocytes, suggesting the presence of Abs that possibly recognised 
epitopes on T cells and B cells, the hybridomas were screened using only TL’s in the 
Dot blot, relying on the intensity of staining with these to select positive hybridomas. 
It was assumed that a strong Dot blot reaction was indicative of a high detection of 
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TL’s. However, it is possible to find abundant immunogenic moieties in leukocytes (De 
Luca, Wilson & Warr, 1983; Greenlee & Ristow, 1993); hence it is possible that in the 
evaluated pAb, there existed Ab’s that were reacting to common antigens on the 
leukocytes surface. 
The success in producing cell markers that are able to differentiate T-cell 
subpopulations in fish has been very poor. Authors attempting to develop these have 
found that just one clone may have the potential to be a useful marker out of hundreds 
of clones that are produced during the fusion (Scapigliati et al., 1995; Passer et al., 1996; 
Rombout et al., 1997 &, 1998). In the present work, of the 564 clones produced, only 
24 were shown to react with cells from the thymus in the Dot blot, and from the FCM, 
only one of these 24 clones appeared to be able to specifically label lymphocyte-like 
cells. 
The twenty four clones selected by Dot blot gave a strong reaction against 
thymic cells. However, when hybridoma supernatants were screened by IIF staining 
using peripheral blood cells, the proportion of cells detected by FCM was low and 
appeared non-specific. Due to the fact that the antigens used to immunise the mouse 
were thymic cells, it was expected to obtain a higher reaction with thymocytes rather 
than PBLs. The reaction of supernatants from the 24 clones with cells in whole 
peripheral blood was very low and these stained cells outside the R1 region. During the 
development of the mAb DLT15 for sea bass, one of the two mAbs available against 
T-cells of teleosts, was selected from 349 clones, chosen because of its ability to stain 
living and fixed thymocytes (Scapigliati et al., 1995). By FACS these authors obtained 
2.2 % staining of whole blood cells (Scapigliati et al., 1995). Similarly, Passer et al. in 
1996 immunise mice with whole thymic cells and developed a T-cell specific mAb 
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(CfT1) that stained 10 % of PBL´s (not whole blood) when assessed by FCM. In the 
present work, the use of whole peripheral blood for the first screening by FCM, 
permitted the selection of a mAb detecting cells with FSC and SSC similar to that 
obtained for lymphocytes, however very low levels (1.4%) of recognition were 
obtained.  
The second screening by FCM was designed as an attempt to enrich the T-cell 
population by using a multiple way activation by recognisement of foreign 
histocompatibility complex (mHCA) and Con A stimulation, and hopefully leaving 
granulocytes, thrombocytes, and monocytes unstained. However, due to the incipient 
experience on FCM during evaluation, the selection of appropriate controls that 
facilitated the analysis was lacking (i.e. positive and no-immunised mouse serum). 
However, taking the previous into account during analysis, the mAb TcOm15 was 
considered a potential positive due to the reaction against a cluster of cells that several 
authors consider as mainly a lymphocyte population, and out of the precursors and 
debris area (Scharsack, 2001; Kfoury et al., 1999, Chilmonczyk, 1999).  Additionally, the 
mAb TcOm15 detected an increase by 1.7 to 2 times in number of labelled cells treated 
with mitogen Con A, localised by FSC/SSC similarly to the cells detected in the 
mHCA without Con A. Passer et al. (1996) clearly demonstrated the ability of the cell 
marker CfT1 to detect Con A stimulated cells which increased ~5 times when 
compared with a control and stimulus with a B-cell activator (LPS). Due to the 
modifications made to the stimulation assay (mHCA and Con A) for the screening of 
the mAb´s in this investigation, it was possible that there was activation for a 
subpopulation of cells but suppression of another population. However, due to the 
detection of differences in numbers of cells in the emHCA when compared with 
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bmHCA, it was assumed that mAb TcOm15 labelled cells with lymphocyte 
characteristics that showed up-regulation of surface molecules related with the 
allogeneic stimulation in the presence of Con A. The identity of the cells, and the 
antigen on the cells, recognised by this mAb, and the dynamics of its staining were 
investigated further in Chapters 3 and 4. 
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Chapter 4 Identification of  the Antigen Recognised by mAb 
TcOm15  
4.1 Introduction 
Monoclonal antibodies (mAbs) are highly specific for the antigenic molecules 
they have been raised against. This specificity can be used to identify particular 
components such as receptors, molecules associated with cell activation, and 
adhesion markers within complex systems such as cellular membranes (Goldrath et 
al., 1995). The detection of surface marker molecules on immunological cells can 
help to identify and elucidate cellular components of the immune response. The 
expression of these molecules on a particular leukocyte population depends on the 
morphological and/or functional differentiation of the leukocyte lineage that the 
leukocytes belong to (Scapigliati, Romano & Abelli, 1999; Moulana, et al., 2008; 
LeBien & Tedder, 2009). Thanks to the availability of cell markers, studies on 
human immunology have demonstrated that surface molecules on leukocytes have 
important functions, such as receptors that bind antigens, ligands involved in cell to 
cell signaling or in initiating immune response activity (LeBien & Tedder, 2009). 
Not only have mAbs been used to discriminate cells during different stages of cell 
development, but have assisted in understanding the dynamics of the molecule’s 
expression during functional processes. Such molecules detected on human 
leukocytes have been named human leukocyte differentiation antigens or HLDA. In 
order to group the antibodies that detect similar molecules and have similar patterns 
of reaction, human immunologists have organised the mAbs using the nomenclature 
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scheme, Clusters of Differentiation (CD). So far, there are about 350 leukocytes 
surface molecules detected by mAbs with a CD nomenclature for human leukocytes 
(www.hcdm.org). Workshops are organised annually to discuss how new antibodies 
fit into this nomenclature scheme.  
A greater understanding about the types of mAbs available for swine 
immunology came from the animal sections held at the HDLA workshop, leading to 
studies in which the lineages and subsets of cells involved in the immune response 
of swine were examined (Haverson et al., 2001). According to Piriou-Guzylack & 
Salmon (2008), the progress made in swine immunology in recent years has been 
achieved through the classification assignment of CD nomenclature to mAbs 
against swine leukocytes. The criteria used to establish an official swine CD 
nomenclature are based on: (1) “the binding to the cluster of two or more mAb 
resulted in a pattern of reactivity that is typical of the same CD marker seen on 
human cells”, (2) “the molecular weight (MW) of the antigen recognised by the 
mAb is similar to that of the human antigen” and (3) “the reactivity with the gene 
product or functional studies of the identified molecule” (Piriou-Guzylack & 
Salmon, 2008 page 3). Monoclonal antibodies used to identify surface molecules on 
pig leukocytes are able to differentiate cell types from lymphoid and myeloid 
lineages into T-cells, natural killer cells, B-cells, monocytes, macrophages and 
dendritic cells. It is also possible to examine different functions as activation, 
adhesion and attachment as well as identifying functional molecules during the 
immune response of pigs (see Figure 3.1). 
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However, as yet no similar nomenclature exists for teleosts (Fischer & 
Koellner, 2007). In fish immunology there is a great need to produce mAbs that are 
able to differentiate the various components of the fish immune system and to help 
understand the behaviour of the fish immune response. 
 
 
Figure 4.1  Example of clusters of discrimination used to phenotype blood swine 
leukocytes, macrophages and dendritic cells using CD mAbs (from Piriou-
Guzylack & Salmon, 2008, page 16).  
 
It is still not possible to describe the role of the different membrane 
molecules of leukocytes during recognition of antigens and the physiological 
communication between immune cells of fish. As mentioned earlier in Chapters 1 
and 2, there are very few mAb cell markers available for fish. In an effort to identify 
mAbs which might be useful for teleosts, 382 mAbs commercially available for 
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humans were recently tested against rainbow trout and carp cells (Fisher & 
Koellner, 2007). From this long list, only 4 mAbs showed any reaction with 
leukocytes from trout (mAbs anti-human CD14, CD20cy, CD45RO and Xg 
molecules) and 2 against carp cells (mAbs anti-human CD20cy, and CD45RO 
molecules) by flow cytometry. However, only one of these showed any reaction in 
immunohistochemistry (IHC), and none were reactive in Western blot analysis or 
immunoprecipitation (Fisher & Koellner, 2007). Even though a reaction was 
obtained with the human mAbs, the possibility that these mAbs were able to 
identify identical CD markers in fish could only be demonstrated through functional 
assays. Several mAbs have now been developed for fish, as shown in Table 1.3 in 
Chapter 1. However, it is necessary to look at the reactivity of all these mAbs in a 
teleost workshop with the purpose of identifying possible clusters where these can 
be assigned and to initiate a nomenclature system for fish.  
 
Aim: 
Given the findings in Chapter 2, the aim of the present chapter was to 
determine which types of cells that were recognised by mAb TcOm15 and to 
identify the antigen being detected by the mAb. Cells and tissues stained with the 
mAb were analysed by microscopy, proteins from leukocytes were extracted and 
immunodetection was performed with the mAb in an attempt to identify the antigen 
and possibly establish its identity by Mass Spectrometry (MALDI-TOF) analysis.  
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4.2 Material and methods  
4.2.1 Isolation of leukocytes  
Gills, thymus, spleen, liver, head kidney, and intestine were removed and 
leukocytes were isolated and washed with PBS at 1000 x g for 10 min at 4oC. The 
cell concentration was determined (Section 2.2.1) and cells were used as required for 
each of the following protocols. 
4.2.2 Flow cytometry (FCM) 
Immunolabelling of cells from different organs was carried out to determine 
the proportions of leukocytes labelled with mAb TcOm15 from the different 
tissues. The methodology was performed as described in Section 2.2.4. 
4.2.3 Microscopy 
4.2.3.1     Immunohistochemistry (IHC) 
Samples were processed according to Adams and Marin de Mateo (1994). 
Tissues from the various organs (thymus, spleen, gill, liver, intestine, and head 
kidney) were fixed with 10 % neutral buffered formalin. Tissue was embedded in 
paraffin, and 5 m sections were cut and placed on microscope slides. Tissue 
sections were dewaxed and rehydrated in xylene (2 times for 5 min), in 100 % 
ethanol for 5 min, in 70 % ethanol for 3 min. Endogenous peroxidase activity was 
blocked by incubating the slides for 10 min at 21oC with H2O2 in methanol and 
washed three times with PBS. Non-specific binding sites were blocked with normal 
goat serum diluted 1/10 in PBS for 20 min at 21oC. Tissue sections were circled 
with a wax pen and then covered with hybridoma supernatant containing mAb 
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TcOm15 and incubated for 30 min at 21oC in a humid chamber before washing 
three times with PBS. Goat anti-mouse IgG HRP conjugate (Vector, Peterborough 
UK) diluted 1/200 in PBS was added to the slides for 30 min. Finally, the reaction 
was visualised by incubating the slides for 10 min with substrate using a Vector VIP 
Peroxidase Substrate Kit following the manufactures instructions. The tissue 
sections were counter-stained with methyl green (Vector) for 5 min following the 
manufactures instructions and mounted for microscopy observation. 
4.2.3.2     Indirect immunofluorescence (IIF) 
The IIF protocol was performed using the tissue sections and the IHC 
protocol described in Section 3.2.3.1 with modifications. The HRP conjugate was 
substituted with a rabbit anti-mouse FITC conjugate (Sigma Aldrich), diluted 1:50 
with PBS containing 1 % BSA, incubating with this for 30 min. Slides were washed 
with PBS and mounted using Vector mounting shield containing DAPI (which 
stains DNA). The slides were maintained in the dark until observed under a Leica 
TCS SP2 AOBS Confocal scanning laser microscope. Images were captured using 
Leica Confocal software and lasers lines at 405nm, 488nm and 594nm. 
Indirect immunofluorescence was also performed on PBLs (1 x 108 cells/ml) 
that had been allowed to adhere to μ-VI flat Ibidi slides (IBIDI, Munich, Germany) 
coated with poly-L-lysine for 1 h. Wells were washed with PBS containing 0.5% 
BSA and incubated with hybridoma supernatant containing mAb TcOm15 for 30 
min. The secondary antibody used was an anti-mouse IgG conjugated with Texas 
Red (1.5 μg/ml) (Vector), incubating with this for 30 min. Wells were then washed 
three times with PBS. Cells were fixed with 2 % paraformaldehyde containing 3 % 
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sucrose in PBS for 20 min. Finally, cells were permeabilized with PBS plus 0.5 % 
Triton X-100 (Sigma Aldrich) for 10 min, and 2.5 % of methanolic solution of 
Alexa Fluor 488 Phalloidin (Invitrogen) in PBS (pH 7.4) was added for 20 min to 
stain F-actin. Vector mounting shield containing DAPI was added to the slides, and 
the cells covered with a coverslip then maintained in the dark until observed under a 
confocal microscope. 
4.2.4 Characterisation of antigen recognised by mAb TcOm15 by 
gel electrophoresis 
4.2.4.1     Cell lysates and sample preparation 
Cells were isolated, as described previously in Chapter 2, and a sample from 
the mucus of skin was also obtained by scraping the fish with a scalpel to obtain 
approximately 0.5 ml of mucus. Proteins were extracted from the cells and mucus 
using six different detergents. A basic lysis buffer was prepared according to 
Camacho-Carvajal et al. (2004) containing 50 mM Tris-HCl, pH 7.5, 25 mM of NaCl 
and 1 mM of EDTA. One of the 6 different detergents was added to this basic 
solution, these being either 0.1 % of Saponin (Sigma Aldrich), 0.1 % of Triton X-
100 (Sigma Aldrich), 0.1 % of Tween 20 (Sigma Aldrich),  0.1 % of Nonidet P-40 
(Sigma Aldrich), 0.1 % of Tween 80 (Sigma Aldrich), or 1 % of CHAPS (Fisher 
Scientific, Loughborough, UK) and using 1 mM of phenylmethylsulfonyl fluoride 
(PMSF) (Promega, Southampton, UK) in each preparation as protease inhibitor. 
Cells (1 x106 - 2 x107) were incubated with 250 µl of each lysate buffer for 30 min 
on ice. Once cells were lysed the preparations were centrifugated at 5,000 g for 20 
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min at 4oC. Cell supernatants were retained and kept refrigerated or frozen until 
used.  
4.2.4.2     1D Sodium dodecyl sulphate polyacrylamide gels (SDS-PAGE)  
For SDS-PAGE, supernatants were prepared with sample buffer containing 
100 mM Tris-HCL (pH6.8), 4 % SDS, 2mM DTT, and 0.02 % bromophenol blue 
(Laemmli 1970). Equal volumes of protein sample from Section 3.2.4.1 were mixed 
with a 2x concentration of sample buffer and boiled for 90 sec. Electrophoresis was 
performed according to Laemmli (1970). Twenty µg of the protein lysate from each 
organ was added to one of the lanes. Full range rainbow markers were added as a 
reference in order to compare bands from the Western blot analysis Section 
(3.2.4.4). Electrophoresis was carried out at 130 V and 90 mA until the 
bromophenol blue dye reached the bottom of the gel. Gels were stained with 
Comassie Brilliant Blue (Sigma) and destained with 40 % methanol/10 % acetic 
acid. A silver stain kit (Proteo Silver, Sigma Aldrich) was used to stained samples 
which gave weak staining with Coomassie Blue. 
4.2.4.3     2D Blue native polyacrylamide gels (BN-PAGE) 
In order to investigate membrane-bound complexes native gels were 
prepared with modifications according to Camacho-Carvajal et al. (2004), Lehner, 
Niehof & Borlak (2003), Nijtmans et al. (2002), and Schagger et al. (1991).  
a) Protein supernatants/whole leukocytes lysates 
Protein samples described in Section 3.2.4.1 were eluted through a filter 
column in order to eliminate small molecules and help improve the resolution of the 
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electrophoresis run under native conditions. Supernatants were centrifugated in a 
filter column (Microcon YM10; Millipore) where 375 µl of BN buffer (500 mM -
amino caproic acid, 20 mM Bis-Tris, pH 7.0, 2 mM EDTA, 12 mM NaCl, 10 % 
glycerol, detergent and 1 mM phenylmethylsulfonyl fluoride) was added to the 
column. After centrifugation for 45 min at 15,000 x g at 4 °C, the flow-through from 
the column was discarded and the concentrated protein solution used for gel 
electrophoresis. The procedure was repeated two times with 450 µl of cold BN 
buffer (Camacho-Carvajal et al., 2004). 
b) 1D BN-PAGE 
BN-PAGE electrophoresis was performed by preparing 5 %-13 % gradient 
native polyacrylamide gels (0.75 mm thick) according to Table 3.1 & Figure 3.2 A.  
Buffers used for the BN-PAGE were prepared as follows: Blue Cathode Buffer 
(50 mM Tricine, 15 mM Bis-Tris and 0.02 % of Coomassie Blue G250 (Sigma)), 
Anode Buffer (50 mM Bis-Tris) and 3x Buffer (200 mM -Amino Caproic acid, 
150 mM Bis-Tris). The cathode and 3x buffers were adjusted to pH 7 with HCl 
(4oC).  
The mini-Protean II electrophoresis system (BioRad labs Ltd.) was prepared 
according to the manufacturer’s manual. Anode Buffer was first added to the 
reservoir in the lower chamber, and then the Blue Cathode Buffer was added to the 
upper chamber taking care to not mix the Cathode and Anode buffers. Samples (20 
µl) were added to the sample wells, and ferritin (10mg/ml) and BSA (10mg/ml) in 
BN buffer were added to an additional well as MW markers.  
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Table 4.1  Volumes of reagents used to prepare gradient gels (modified from 
Nijtmans et al., 2002). 
 
Solution 
A 
5 % 
B 
13 % 
Stacking  
4 % 
Acryl-Bis mix 
(48:1) 
1.01 ml 2.60 ml 0.40 ml 
3x buffer 3.33 ml 3.33 ml 1.67 ml 
water 5.39 ml 1.98 ml 2.87 ml 
glycerol 0 2.00 ml 0 
10 % APS 60.0 µl 30.0 µl 55.0 µl 
TEMED 6.0 µl 3.0 µl 5.5 µl 
Total volume 10 ml 10 ml 5 ml 
 
 
During the BN electrophoresis, the proteins in the samples acquire their 
negative charge from the Coomassie Blue. The samples were first subjected to 80 V 
until the samples were observed to penetrate the gradient gel, and once in the 
gradient gel (separating gel) the voltage was increased to 200 V. The electrophoresis 
apparatus was connected to a water cooler (LEEC Incubator) to maintain the 
temperature of the gel at 4oC during the electrophoresis procedure. After having 
reached the middle part of the gel, the Blue Cathode buffer was exchanged for a 
buffer prepared as described for the Blue Cathode buffer but without the 
Coomassie Blue (i.e. it was colourless), so this buffer destained the gel during the 
rest of the run.  Once the electrophoresis run was completed, the gels were stained 
as described for SDS-PAGE in Section 3.2.4.2. 
c)  2D SDS-PAGE 
Once the BN-PAGE was complete, a lane was sliced from the gel as shown 
in Figure 3.2 and equilibrated for 15 min in Laemmli loading buffer (2x SDS). The 
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strip of the gel was placed horizontally onto a 10 % SDS gel with a 1.5 mm 
thickness, taking care to not introduce any bubbles between the interfaces of the 
two gels (Laemmli, 1970) as shown in Figure 3.2 B. A gap was introduced to the left 
of the 1D gel (BN) so that 20 μl of Full Range Rainbow marker (Amersham) could 
be added to the gel.  The SDS-gel was run at 200 V until the bromophenol blue dye 
reached the bottom of the gel. Subsequent staining procedures were as described for 
the SDS-PAGE outlined in Section 3.2.4.2. 
 
Figure 4.2. 2D Blue Native polyacrylamide gel electrophoresis. (A) Flow diagram of 
BN-PAGE procedure, i.e. extraction of protein, elution to remove small (< 10 
kDa), running of 1D gradients gels, running of cut sample lane from 1D on SDS-
PAGE gels for 2D analysis, and staining to visualise separated proteins; (B) 
Principle of 2DBN/SDS-PAGE. Cut lane from 1D BN-PAGE contain protein 
complex separated according to their size by the gradient gel, bigger at top and 
smaller complexes at the bottom of the lane. After SDS-PAGE run of the cut 
lane, the components of every complex are separated according size (image from 
Camacho-Carvajal et al., 2004, page 177). 
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4.2.4.4     Western Blotting (WB) 
In order to determine which proteins were being recognized by mAb 
TcOm15, the gels from SDS-PAGE and BN-PAGE were immunoblotted with the 
mAb. Firstly, proteins separated by electrophoresis were transferred onto a 
nitrocellulose membrane according to Wiens (1990). The nitrocellulose membrane 
was then incubated in 1 % BSA in Tris-buffered saline (TBS) for at least 60 min at 
21oC to block non-specific binding sites on the membrane. The nitrocellulose paper 
was then washed 3 times with TTBS (Tris buffered saline plus 0.1 % of Tween 20) 
for 5 min on each wash. Next, the membrane was incubated with hybridoma 
supernatant containing mAb TcOm15 for a minimum of 1 h and again washed as 
described above. An anti-mouse IgG biotinylated second antibody (Sigma Aldrich) 
diluted 1:200 in TBS was added for 60 min and the blot was again washed as 
described above. The blot was incubated for a further 60 min with streptavidin-
HRP (Vector) diluted 1:200 in TBS and washed as described giving a fourth wash 
with TBS without Tween 20. The blot was finally developed with a KPL 4CN 
substrate kit (KPL, Maryland, USA) according to manufacturer’s instructions.  
4.2.5 Immunoprecipitation (IP) 
4.2.5.1     Sequential extraction of proteins 
Sequential extraction of proteins was performed according to Lehner et al. 
(2003). Cytosol proteins were extracted in buffer containing 40 mM Tris and 150 
units ml-1 Benzonase (Sigma Aldrich) using sonication to mechanically disrupt the 
cells (Lehner et al., 2003). Samples were vortexed for 5 min, and sonicated for 10 
 64 
 
min, repeating this process twice. The membrane proteins were then extracted using 
CHAPS 1 % as described in Section 3.2.4.1. 
In order to reduce the amount of contaminating proteins in the sample lysate 
a pre-clearing step was performed by incubating 450 µl of cell lysates with 50 µl 
prepared Protein G slurry (Sigma) for 45 min on ice according to eBiosciences 
protocol (www.ebioscience.com/ebioscience/appls/IP.htm). After incubation, the 
sample was centrifugated at 10,000 g for 10 min to remove the Protein G slurry. 
The supernatant was then recovered and used for immunoprecipitation (IP). 
4.2.5.2     Immunoprecipitation (IP) 
The supernatant collected in Section 3.2.5.1 was incubated overnight at 4oC 
with 200 µl of hybridoma supernatant containing mAb TcOm15. Protein G slurry 
was prepared in cold Lysis Buffer and 50 µl of this was added to the ag-ab complex. 
After 1 h at 4oC, the sample was centrifugated at 10,000 g for 30 sec and the protein 
G pellet collected. The Protein G beads containing the ag-ab complexes were 
extensively washed with 500 µl of cold lysis buffer and after centrifuging again the 
supernatant was removed from the pellet. Protein G beads were finally vortexed and 
heated for 10 min at 100oC with 1x Laemmli Sample Buffer (www.ebioscience.com/ 
ebioscience/appls/IP.htm). To recover the supernatant, the sample was 
centrifugated at 10,000 g for 30 sec and the supernatant used for SDS-PAGE and 
WB analysis according to Sections 3.2.4.2 and 3.2.4.4. 
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4.2.6 Protein identification 
The antigen bound to mAb TcOm15 in the WB analysis were selected for 
identification by mass spectrometry. Protein samples were prepared from cells using 
lysis buffer (50mM Tris-HCl pH7.5, 25 mM NaCl, 1 mM EDTA, and 0.5 % NP40), 
and this was then sent for analysis by the FingerPrints Proteomics Facility at 
University of Dundee, UK. To increase the yield of proteins detected by Commassie 
Blue in SDS-PAGE, samples were concentrated using centrifugation in a filter 
column (Microcon YM30; Millipore). At the Proteomics Facility, samples were 
separated by electrophoresis, stained with colloidal Coomassie Blue and reductively 
alkylated in-gel. Bands of interest were selected and digested in 0.1 % n-Octyl 
Glucoside /20mM Ammonium Bicarbonate containing 12.5 µg/ml trypsin. Then, 
20 µl of acetonitrile (ACN) were added to 20 µl of sample extract and 2.0 µl of the 
samples were spotted for peptide mass fingerprinting by MALDI-TOF or ESI 
MS/MS. 
 
4.3 Results 
4.3.1 Flow cytometry (FCM) 
Levels of leukocytes in different tissues (PBL, thymus, spleen, and head 
kidney) were determined by staining the cells with mAb TcOm15 and analysed by 
FCM (Figure 3.3). The percentage of total positive leukocytes was highest in 
peripheral blood (39.4 % ± 3.2), moderate in spleen and head kidney (20.6 % ± 0.9 
and 10.8 % ± 0.9), and very low in the thymus (7.1 % ± 0.8), as shown in Table 3.2. 
For all four organs examined, the highest number of labelled cells was observed in 
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the lymphocyte region (RLymph) of the dot plot in contrast to the granulocyte 
region (RGran), where stained cells were scarce. Leukocytes from peripheral blood 
were stained in a proportion of 27.1 % ±1.4 in the RLymph region and 9.3 % ±0.6 
in the RGran region, while 13.8 % ±0.4 of spleen leukocytes were stained in the 
RLymph region and 4.5 % ±0.1 in RGran region when labelled with the mAb, and 
for head kidney 5.6 % ±0.6 of cells in the RLymph region and 4.5 % ±0.1 in the 
RGran region were stained. The exception was in the thymus, where a slightly 
higher number of reactive cells were seen in the RGran region of the dot plot i.e. 2.5 
% ±0.3 compared to the proportion seen in the RLymph region, i.e. 2.0 % ±0.2 
(Table 3.2 & Figure 3.4). A small percentage of staining was seen in the region 
marked as R1, for all organs where debris tends to be located (see Figure 3.4 and 
Table 3.2). 
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Figure 4.3 Example dot plots showing labelled cells in red for gate R1 (debris cells), 
R2Lymph (Lymphocytes), RGran (Granulocytes). PBL, peripheral blood 
leukocytes; TH, thymus; SP, spleen; HK, head kidney. 
 
 
Positively labelled leukocytes in the peripheral blood and the spleen had a 
high measure of FSC and SSC in the region where lymphocytes are located and 
fewer cells were measured in the region where granulocytes can be found. 
Conversely, the proportion of positive cells, labelled with the mAb, seen in the head 
kidney and thymus populations of cells were similar for both the granulocyte region 
and the lymphocyte region (Table 3.2). Different percentages of TcOm15+ cells 
were obtained in the different organs examined for the three different fish analysed, 
however the pattern of labelling in the various organs was very similar between the 
three fish i.e. a high level of labelling with the PBLs, with a lower level of staining 
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with cells in the spleen, and head kidney and a small number of stained cells in the 
thymus (Table 3.2). 
 
Table 4.2. Total percentages of leukocytes labelled with mAb TcOm15 in peripheral 
blood, thymus, spleen, and head kidney. 
 
  Percentage ± s. d. 
PBL 
R1 3.0 ± 1.3 
Rgran 9.3 ± 0.6 
RLymph 27.1 ±1.4 
TOTAL 39.4 ± 3.2 
TH 
R1 2.6 ± 0.3 
Rgran 2.5 ± 0.3 
RLymph 2.0 ± 0.2 
TOTAL 7.1 ± 0.8 
SP 
R1 2.3 ± 0.4 
Rgran 4.5 ± 0.1 
RLymph 13.8 ± 0.4 
TOTAL 20.6 ± 0.9 
HK 
R1 0.7 ± 0.2 
Rgran 4.5 ± 0.1 
RLymph 5.6 ± 0.6 
TOTAL 10.8 ± 0.9 
The results are presented as the mean ±s.d. for four organs from three fish with three 
replicate from each fish minus the background control value. PBL, peripheral blood 
leukocytes; TH, thymus; SP, spleen; HK, head kidney; R1 (primordial cells), R2Lymph 
(Lymphocytes), RGran (Granulocytes).  
 
4.3.2 Microscope observation 
4.3.2.1     Immunohistochemistry (IHC) 
Positive staining was observed in all the tissues examined by IHC i.e. gills, 
thymus, spleen, head kidney, liver, and intestine. 
Gills: tissue was strongly stained with mAb TcOm15 with preferential 
staining seen in the epithelial region of the tissue (Figure 3.4). Individual cells were 
stained in the primary lamellae with mAb TcOm15 (Figure 3.4 c & d).  
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Thymus: TcOm15+ cells seen in this tissue were restricted to the cortex of 
the thymus next to the epithelial cells of the branquial cavity. Groups of labelled 
cells were detected near to the cortex (see Figure 3.5 c & d). In contrast, cells from 
the medulla did not show any reaction with the mAb (see Figure 3.5 e). All thymus 
tissue appeared stained with the pAb serum collected from the fusion mouse when 
used as a positive control. No reaction was seen in the thymus tissue with the 
negative control (i.e. PBS). 
Spleen: Positive staining was seen in the spleen with mAb TcOm15 (Figure 
3.6). Stained cells were seen scattered throughout the tissue and the cells stained 
appeared “active” as it was possible to observe filopodia on cells (see Figure 3.6). 
Cells in spleen tissue did not show any preferential distribution of staining with the 
mAb.  
Liver: The pAb gave a patchy pattern of staining in the lobules of liver tissue 
when used to stain this tissue (Figure 3.7 b and c). When liver was stained with the 
mAb numerous cells were labelled, and these were seen scattered throughout the 
liver tissue (Figure 3.7 d, e and f). Filopodia and pseudopodia, resembling 
interacting cells, were observed on many pairs or groups of labelled cells (Figure 3.7 
e & f).  
Head kidney: The pattern of cells stained with the mAb in the head kidney 
tissue, as shown Figure 3.8, was similar to that observed in the spleen with stained 
cells seen scattered throughout the tissue.  
Intestine: The intestine displayed distinct staining with mAb TcOm15, 
reacting strongly with the contents of some goblet cells and secreted mucus (Figure 
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3.9). However, there were differences in the pattern of staining between the anterior 
and posterior intestine with the end of the intestinal tube being more reactive 
(Figure 3.9 e and f). Few stained cells were observed in lamina propia of intestine by 
IHC. 
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Figure 4.4 Immunohistochemistry of gills from rainbow trout. a) gill filament 
negative (i.e. PBS added in place of primary antibody), b) primary lamellae 
stained with polyclonal from M1CA, c), d), e) and f) stained with mAb TcOm15. 
e) tip of the primary lamellae showing strong staining of epithelia, and f) base of 
gill filament. Orange arrows, positive cells. Red arrow, strong epithelial staining. 
EC, epithelial cells. 
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Figure 4.5 Immunohistochemistry of thymus from rainbow trout. a) tissue prepared 
as negative (i.e. PBS added in place of primary antibody), b) tissue stained with 
polyclonal from M1CA, c), d), e) and f) stained with mAb TcOm15. d) mAb 
TcOm15s showing labelled cells in groups (orange arrows), e) tissue from 
medulla (M) stained with mAb TcOm15 showing no reaction, f) stained cells 
from the cortex border (C) (orange arrows). EC, epithelial cortex. 
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Figure 4.6 Immunohistochemistry of spleen from rainbow trout. a) and b) tissue 
prepared as negative (i.e. PBS added in place of primary antibody), c), d) e) and 
f) tissue stained with mAb TcOm15 (orange arrows show positive staining of 
cells), and filopodia can be observed in stained cells with mAb Tcom15 in f) 
indicated by green arrows. mm, melanomacrophages. Note: No polyclonal 
staining image was obtained. 
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Figure 4.7 Immunohistochemistry of liver from rainbow trout. a) tissue prepared as 
negative (i.e. PBS added in place of primary antibody), b) and c) tissue stained 
with polyclonal from M1CA showing patched pattern of staining, d), e) and f) 
stained with mAb TcOm15. d) and e) tissue stained with mAb TcOm15 (orange 
arrows show positive staining of cells), and filopodia can be observed in stained 
cells with mAb TcOm15 in e) and f) indicated by green arrows.  
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Figure 4.8 Immunohistochemistry of head kidney from rainbow trout. a) tissue 
prepared as negative (i.e. PBS added in place of primary antibody), b) tissue 
stained with polyclonal from M1CA, c), d), e) and f) stained with mAb TcOm15. 
Orange arrows show positive staining of cells. mm, melanomacrophages. 
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Figure 4.9 Immunohistochemistry of intestine from rainbow trout.  a) tissue 
prepared as negative (i.e. PBS added in place of primary antibody), b) tissue 
stained with polyclonal from M1CA, c), d), e) and f) stained with mAb TcOm15. 
c) and d) IHC of anterior intestine, e) and f) IHC from posterior intestine. Red 
arrows show staining of mucus and some goblet cells. L, lumen. 
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4.3.2.2     Confocal microscopy 
Peripheral blood cells were stained with mAb TcOm15 then viewed under a 
confocal microscope. Detailed observations indicated that  certain cells did not stain 
with mAb TcOm15 (Figure 3.10 a). Stained cells that appeared to be granulocytes or 
lymphocytes showed polarisation of red staining that co-localised (white) with F-
actin in green (Figure 3.10 b & c). The mAb react with lymphocyte-like cells, which 
were shown to have condensed cytoplasm and rounded nuclei (Figure 3.11). The 
cells had diffuse staining with the mAb over the whole membrane, as indicated by 
the red staining from the texas red fluorescent label used to identify binding with 
the mAb. Colocalisation of F-actin (indicated by green phalloidin), and the mAb 
TcOm15 reactive molecule (red) was observed (Figure 3.11). Monocyte-like cells 
with ruffling membranes were detected showing an irregular spotted staining with 
the mAb but not colocalization was detected (Figure 3.12). In Figure 3.13, it is 
possible to observe a lymphocyte-like cell and a monocyte-like cell where an 
apparent polarized staining was observed. Neither thrombocytes nor erythrocytes 
appeared to stain with the mAb TcOm15. 
Due to the strong reaction observed with the mucus and secretions from 
goblets cells, some tissue sections were also prepared for confocal microscopy. 
When intestine was examined under the confocal microscope it was possible to 
visualise cells that reacted with mAb TcOm15 as shown in Figure 3.14. The strong 
reaction seen in IHC coincided with the staining seen under confocal microscopy, 
i.e. labelling of mucus and the secretions of some goblet cells in the posterior part of 
intestine, and negative controls were not stained observed (images not processed). 
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Figure 4.10 Confocal image of peripheral blood leukocytes from rainbow trout stained with mAb TcOm15 and anti-mouse Texas 
Red conjugate. a) image of monocyte-like cell showing no stain, b) granulocyte-like and lymphocyte-like cells with merged 
channels, and c) granulocyte-like and lymphocyte-like cells showing colocalization in white. Blue, nuclei stained with DAPI; 
green, actin stained with phalloidin; and red, TcOm15+ molecule labelled with Texas Red.  
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Figure 4.11 Confocal image of peripheral blood leukocytes from rainbow trout stained with mAb TcOm15 and anti-mouse Texas Red 
conjugate. a) image of lymphocyte-like cells with merged channels, b) separated channel for mAb TcOm15 in the Red channel, 
and c) image showing colocalization in white. Blue, nuclei stained with DAPI; green, actin stained with phalloidin; and red, 
TcOm15+ molecule labelled with Texas Red. Blue arrow shows a ring formation in the cytoskeleton. 
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Figure 4.12 Confocal image of peripheral blood leukocytes from rainbow trout stained with mAb TcOm15 and anti-mouse Texas 
Red conjugate. a) Image of monocyte-like cell using merged channels, b) separated channel for mAb TcOm15 Red, and c) F-
actin in the green channel. Blue, nuclei stained with DAPI; green, actin stained with phalloidin; and red, TcOm15+ molecule 
labelled with Texas Red. 
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Figure 4.13 Confocal image of peripheral blood leukocytes from rainbow trout stained with mAb TcOm15 and anti-mouse Texas 
Red conjugate. a) image of a lymphocyte-like cell and a monocyte-like cell using merged channels, b) separated channel for 
TcOm15 in Red, and c) F-actin in the green channel. Blue, nuclei stained with DAPI; green, actin stained with phalloidin; and 
red, TcOm15+ molecule labelled with Texas Red.  
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Figure 4.14 Confocal image of intestine from rainbow trout. a) and b) tissue stained 
with mAb TcOm15 and anti-mouse FITC conjugate (Green).  Red arrows show 
staining of mucus and goblet cells. Orange arrow, stained cells. L, lumen.  
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4.3.3 Antigen identification 
4.3.3.1     1D SDS-PAGE and WB 
Polyacrylamide gel electrophoresis was used in order to determine the 
molecular weight of the antigen recognised by mAb TcOm15. As an initial 
approach, several detergents were tested in order to select the detergent that gave 
the better resolution of cell profiles in gel electrophoresis. Samples of PBL were 
lysed as described in Section 3.2.4.1. Nonidet NP40 was the detergent finally 
selected for lysis of cells as this detergent enabled optimal resolution of the protein 
bands (Figure 3.15 lane 4).  
 
Figure 4.15 SDS-PAGE of cell lysates from rainbow trout PBLs extracted with 6 
different detergents and stained with a) Coomassie Blue and b) silver stain. 
Lanes: (1) Saponin; (2) Triton x-100; (3) Tween 20; (4) NP40; (5) Tween 80; (6) 
CHAPS. 
 
 
Several bands were detected by mAb TcOm15 in the solubilised leukocyte 
protein extracts prepared from different tissues treated with detergent NP40.  
Smeared staining was observed when gills, thymus, intestine, and mucus when 
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stained with mAb TcOm15 in Western blot analysis (Figure 3.16 & Figure 3.17). 
Intestine lysates had the highest number of proteins detected, but strong smearing 
was noted with this tissue (Figure 3.16). For proteins extracted from skin mucus an 
additional protein at 90 kDa was detected (Figure 3.16), and in gill and thymus a 
double band at 60 kDa was observed (Figure 3.17). Three proteins bands were 
detected at 280 kDa, at 160 kDa and 105 kDa in Western blot in spleen and head 
kidney tissue leukocytes (Figure 3.16 & Figure 3.17). When avidin amplification was 
used, faint bands at 280, 160 and 105 kDa were observed in PBLs and thymus 
(Figure 3.17). Two more bands at 70 and 130 kDa were detected due to a cross-
reaction of the amplification (Figure 3.17). Protein bands detected by mAb TcOm15 
in Western blot analysis, common between the PBL, thymus, spleen and head 
kidney tissue leukocytes were prepared for MS identification (i.e. 280, 160 and 105 
kDa) (Figure 3.16 & Figure 3.17). 
4.3.3.2     2D Blue native-PAGE and Western blotting (WB) 
Further analysis of the antigen recognised by mAb TcOm15 was performed 
using two dimension gels under native conditions (BN-PAGE) to establish if the 
bands detected in WB were part of a complex of proteins.  
Proteins from PBL were extracted with buffers containing one of the six 
detergents mentioned above. Solubilised proteins extracted with 1 % of CHAPS 
gave the best resolution after electrophoresis as observed in Figure 3.18. Previous 
attempts to run electrophoresis showed smearing when proteins were extracted with 
Tween 80 (0.1 %), a problem that was resolved by using the detergent CHAPS (1 
%).  
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Solubilised proteins from leukocytes isolated from different tissues were 
separated on linear 5-13 % gradient polyacrylamide gels. Several bands were 
obtained showing successful separation of the proteins. However, when attempts 
were made to perform Western blot on the 1D BN gels (nature conditions), it was 
not possible to successfully transfer the proteins onto the nitrocellulose membrane. 
Due to the higher resolution and greater band definition obtained using denaturing 
conditions (Figure 3.18) and non-denaturing conditions for proteins from spleen 
leukocytes (Figure 3.19), these cells were used as the samples for the 2D gels. 
Initially WB analysis of 2D gels with mAb TcOm15 gave a reaction with a band 
between 80 and 250 kDa in a 10 % gel (Figure 3.20 indicated by the red boxes). 
However, it was not possible to observe this reaction again when the assay was 
repeated. 
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Figure 4.16 Gel electrophoresis and Western blotting analysis of eight different 
tissues from rainbow trout. a) SDS-PAGE stained with Coomassie Blue, b) Silver 
stained, and c) Western blot with mAb TcOm15, arrows indicate common 
proteins bands found in spleen and head kidney leukocytes. 7 % gels under 
reducing conditions. (1) PBL, (2) gills, (3) thymus, (4) spleen, (5) liver, (6) head 
kidney, (7) intestine, (8) mucus. 
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Figure 4.17 Western blot analysis with mAb TcOm15 and marked with a box the 
proteins that cross-reacted with avidin. 7 % gel under denatured conditions. 
Protein leukocytes from Thy, thymus; Spl, spleen; PBL, peripheral blood; and 
Spl control, control for avidin-biotin. (Reaction amplified with avidin-biotin). 
 
 
Figure 4.18 One dimensional blue native polyacrylamide gel showing solubilised 
proteins from PBL extracted with 6 different detergents and stained with 
Comassie Blue. (1) Saponin, (2) Triton X-100, (3) Tween 20, (4) NP40, (5) Tween 
80, (6) CHAPS. 
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Figure 4.19 Gel electrophoresis and Western blotting analysis of eight different tissue 
sources of leukocytes stained with a) Coomassie Blue and b) Silver stain. Gradients 
gels from 5-13 % under nature conditions. (1) PBL, (2) gills, (3) thymus, (4) spleen, 
(5) liver, (6) head kidney, (7) intestine, (8) mucus. 
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Figure 4.20 One dimensional blue native polyacrylamide gel of solubilised proteins 
from spleen cells a) Lanes, (MW) weight markers (ferritin and BSA), (1) Coomassie 
Blue, and (2) Silver stain. b) SDS-PAGE 8 % gel stained with silver showing 
resolved proteins, probably in a complex (blue box 1 and 3), and a single protein 
(blue box 2). c) Western blot gel showing a spot very faintly stained with mAb 
TcOm15 and indicated in b) and c) with a red box. Blue boxes showing proteins 
resolved in two repetitions. 
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4.3.4 Immunoprecipitation (IP) 
Samples of spleen leukocytes were lysed for protein extraction. Proteins binding 
to mAb TcOm15 were immunoprecipitated according to the method described in 
Section 3.2.5. It was possible to isolate three proteins by IP (Figure 3.21) that had 
already been detected by mAb TcOm15 in lysates during Western blot analysis (Figure 
3.15). The IP proteins from the cytosol lysates were detected at 105, 160 and 280 kDa, 
in an equivalent position to the bands previous detected in WB analysis. For 
membrane lysates, a faint band was observed at 105 kDa and another band at 160 kDa 
(Figure 3.21). Results comparable to the IP were obtained when solubilised proteins 
from cytosol and membranes that had not being immunoprecipitated were 
immunoblotted (Figure 3.21).  
 
Figure 4.21 a) Silver stained SDS-PAGE gel of lysates from cytosol (Cyt.) and 
membranes (Mem.) from spleen leukocytes immunoprecipitated (IP) by mAb 
TcOm15 and non immunoprecipitated, and b) Western Blot labelled with TcOm15.  
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4.3.5 Protein identification 
Attempts were made to identify the protein bands detected by the mAb 
TcOm15 in WB. Samples of leukocytes were prepared and sent to the Proteomics 
facility at the University of Dundee for analysis. The bands of interest were removed 
from the SDS-PAGE gel at the facility and the amino acid content of these was 
subsequently determined. The protein at 280 kDa was identified as Myosin (heavy 
polypeptide 10, non-muscle) with a molecular weight, according to the marker used by 
the Dundee facility, of 200 kDa. This protein showed the highest significant (>67) 
score of 127 from 5 different non-mucle myosins showed by the “hit” list during 
blasting with Mascot program.  
From the band at 160 kDa, a long “hit” list (100 proteins) was obtained from 
the database search from which three results were significant. The results showed first 
a protein “Similar to spectrin αII chain (a non-erythroid α chain Spectrin)” with the 
highest score of 186 (>67). Whereas another two identities were immunoglobulins 
identified as Immunoglobulin lambda light chain (Bos Taurus) with a score of 131, and 
another “Similar to immunoglobulin lambda-like polypeptide precursor” with a score 
of 131 was registered.  
The third protein at 105 kDa was identified as an α Actinin-4 (Figure 3.22) with 
a score of 376 from a short “hit” list where another 3 α Actinin-4 from three different 
species was obtained.  
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Figure 4.22 Western blot analysis of solubilised PBLs from rainbow trout with mAb 
TcOm15. Bands could be seen at 280, 160 and 105 kDa. Arrows indicate bands 
which also appeared in the Western blot negative control due to streptavidin 
amplification. 
 
 
It was expected that proteins could be identified by IP, however it was difficult 
to obtain bands distinct enough and at a high enough concentration that could be 
selected for the mass fingerprinting technique. In an effort to obtain enough proteins, 
cells from PB, thymus, and spleen were cultured for 6 days with Con A and then IP 
with mAb TcOm15. This time it was possible to observe a band from the IP protein in 
the area of interest, i.e. a band at 160 kDa. From this preparation, the protein which 
bound to mAb TcOm15 was identified as a protein “similar to membrane-bound 
Immunoglobulin gamma-1 chain C region from Bos Taurus” (Figure 3.23). This 
identification was the only one score (292) significant from a list of 10 proteins 
showed. 
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Figure 4.23  Electrophoresis gels performed at University of Dundee where a 160kDa 
band was isolated with immunoprecipitation of solubilised proteins from PB, 
thymus and spleen. Leukocytes were pooled after culturing for 6 days with Con A. 
Protein from band in red was identified as protein similar to membrane bound IgG1 
C region from Bos taurus. 
 
4.4 Discussion 
Analysis by FCM, microscopy and WB showed that mAb TcOm15 not only 
reacted with thymic cells but also with cells from other tissues. From FCM analysis, the 
lymphocyte population was one of the main groups of cells recognised by this mAb 
(Figure 3.4 b). This region (RLymph) has been confirmed by several authors as a 
region containing populations of lymphocytes and thrombocytes (Romano et al., 1997 
& 1998; Esteban, Muñoz & Messeguer, 2000; Koellner et al., 2001; Jansson et al., 2003; 
Ronneseth, Wegerland & Pettersen, 2007). It is expected that the T-cell population is 
localised in this region, however, the proportions reported for fish T-cells in the 
thymus do not correspond to the ones analysed here by FCM. Of the two markers 
currently available against T-cells from fish, one recognised 73 % of labelled cells in the 
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thymus (Passer et al., 1996) and the other gave a similar value of 74.8 % (Scapigliati et 
al., 1995). The percentage of cells stained by mAb TcOm15 was very low i.e. 7 %. The 
results from IHC on the thymus show cells labelled with the mAb, distributed in the 
cortex of thymus with patches of cells near the thymic cortex. These findings thus 
indicate that mAb TcOm15 detects certain cells in the thymic population. It is 
interesting to note that Romano et al. (2007) found compartmentalisation in thymus i.e. 
cells expressing TcRβ localised in the periphery. This compartmentalisation was 
explained by a migration process where immature cells move from the subcapsular 
zone to the cortex and become mature. It is possible that, due to the fact that the cells 
used to immunise the mouse were activated, that those detected by mAb TcOm15 in 
the cortex are associated with cellular maturation, a presumption that is necessary to 
investigate.  
The cells being labelled by mAb TcOm15 could possibly correspond to a B-cell 
population, however, when labelled cells were observed in IHC or confocal 
microscopy it was possible to observe cells other than lymphocytes being stained with 
the label. In the thymus 7 % of cells were labelled with mAb TcOm15 which was 
higher than labelling seen for Ig markers in the thymus of trout (1 % by 2A1 and 2H9 
mAbs, Sanchez et al., 1995) or 3 % DLIg3 for sea bass B-cells (Romano et al., 1997). A 
considerably higher number of cells were stained in the thymus with mAb TcOm15 in 
IHC analysis compared to the 10 cells per section reported by Scapigliati et al., (1995) 
detected with their DLIg3 mAb against B-cells IgM.  Since the stained cells were 
detected in the lymphocyte region where thrombocytes have been reported, it is 
necessary to point out that cells stained for microscopy with mAb TcOm15 did not 
have the classical spindle shape described for thrombocytes (Koellner et al., 2004). 
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From the results of FCM, another population that may be involved in the 
expression of the molecule recognised by mAb TcOm15 is granulocytes. However, no 
clear recognition was seen in the granulocyte region in FCM; instead disperse labelling 
of cells could be seen (Figure 3.3). Because of the inability to detect higher numbers of 
cells in the head kidney (an important tissue for granulocytes, Mulero et al., 2007), it 
was presumed that mAb TcOm15 does not detect a specific population of 
granulocytes. 
It was therefore concluded that mAb TcOm15 does not detect an antigen that 
can differentiate phenotypic differences between populations of cells, but rather is 
detecting molecules related to a functional state. Staining of PBL, when observed by 
confocal microscopy appeared to have diffuse staining in lymphocyte-like cells, 
possibly associated with the cytoskeleton, due to colocalization of F-actin and the 
TcOm15+ molecule (Figure 3.11, 3.12 & 3.13, F-actin and TcOm15) (Lodish et al., 
2001). It is important to notice that the staining preparation was aimed to detect 
surface molecules and therefore no permeabilization was performed on cells, where in 
such conditions mAb TcOm15 would have reach cytoskeletal molecules on cells. The 
staining in monocyte-like cells was not co-localised with F-actin, and showed a dotted 
pattern of the antigen localisation (Figure 3.14), suggesting no involvement of 
cytoskeletal molecules on those cells. More detailed research is needed in this respect. 
Electrophoresis and Western blotting were performed to determine which 
specific proteins were detected by the mAb. Results of the Western blot using 
electrophoresed proteins under denaturing conditions with leukocytes from several 
different tissues showed that the mAb was not detecting a single protein. At least three 
proteins appeared to be identified by the mAb at 105, 160 and 200 kDa. The proteins 
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were identified as α actinin-4, spectrin αII chain or Ig-like protein and myosin 
(MYH10) by MALDI-TOF analysis and these are molecules that are compositional 
elements for the cytoskeleton of different types of cells (Black et al., 1988; DeMatteis & 
Morrow, 2000, Dustin & Cooper, 2000; Xu et al., 2003). As for spectrin it has been 
suggested that this molecule has, in humans, an important property as a migration 
mediator, and shares a role with actin and myosin, in mechanisms that are involved in 
lymphocyte activation such as cellular polarization and uropodia (Black et al., 1988; 
Gregorio et al., 1992; Evans et al., 1993; Wang, Ostberg & Repasky, 1999; Bialkowska et 
al., 2000). In non-erythroid human cells, spectrin functions as a cross-linker with actin 
filaments to give shape to cells, as a participant in protein sorting, vesicle trafficking or 
endocytosis (Bialkowska et al., 2000). Even when it is ubiquitous in metazoan cells, 
there exist seven encoding genes for spectrin that express seven variants in specific 
cellular patterns, where αII spectrin is common for nucleated cells (Baines, 2010). 
Spectrin however, contains a common domain called SH3, which can be found in 
different proteins that participate in intramolecular interaction, subcellular localisation 
of signals, and mediate multiprotein complexes assemblies (Mayer, 2001). Further, 
spectrin repeats are found in cytoskeletal related proteins (actinin, dystrophin, calyrin, 
etc.) that serve as multivalent binding sites where structural proteins, cell membrane 
receptors, zinc-finger proteins, protein kinases, and other adaptor proteins can  interact  
(Mislow et al., 2002). On the other hand, cytoplasmic domains of transmembrane 
proteins directly interacting with spectrin repeats has been registered for integrins, 
ICAMs, L-selectin, and other receptor subunits (Djinovic-Carugo et al., 2002). 
Therefore, the identification of these proteins by mAb TcOm15 suggests an ability of 
this mAb to detect an epitope appearing during a specific function, possibly related 
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with the synchronicity of expression or interaction for the three proteins identified. 
This hypothesis proposed by the lack of an extensive detection of common 
cytoskeletal proteins during microscopy studies, again indicates a possible recognition 
of the mAb that occur under certain circumstances. Another possibility is a strong 
carrier role during multiprotein complex formation for the interacting proteins. Such a 
carrier role has been reported for instance in α-actinin studies that demonstrate a 
relationship of the cytoskeletal protein with a transmembrane protein (L-selectin) 
evidenced initially by coimmunoprecipitation (Pavalko et al., 2002).  The results from 
the Western blot for cytosolic and membrane solubilised proteins, draws attention to 
the likelihood that the main protein being detected is Ig-like, because this molecule was 
detected more strongly in the membrane fraction. Another result confirms the 
involvement of Ig’s due to the identification of the protein from the band at 160 kDa 
from immunoprecipitated proteins as a membrane-bound IgG-1 chain C region from 
Bos Taurus. On first impressions, it is possible to think that this finding is logical during 
immunoprecipitation due to the fact a mAb was used for the immunoprecipitation 
process. However, the MASCOT search to identify the protein at 160 kDa should have 
been able to give enough data for an IgG from mouse to be detected; instead it 
BLASTED the protein with a bovine IgG from membrane and not a secreted one 
from mouse. It is important to mention at this point that the identification from the 
protein at 160 kDa was difficult given the very low yield of protein for this band. Even 
then, the monoclonal with or without biotinylation always detected this band. 
Membrane bound IgGs are found in B-cells and have been the centre of many studies 
examining their role as membrane receptors (LeBien & Tedder, 2008). Initial studies 
on spectrin in humans aimed to explain the capping behaviour of membrane molecules 
 98 
 
during activation or immunomodulation by mitogens (Turner, Newton & Shotton, 
1988; Wang, Ostberg & Repasky, 1999). The rearrangement of molecules and the 
capping of antigen are thought to be a property of lymphocytes to allow membrane 
components to respond to stimulus during activation or function. With advances in 
human immunology, Masso-Welch et al., (1999) found that the co-polarization of 
spectrin, ankyrin and protein kinase C at the site where membrane immunoglobulin 
from B cells capped was possibly involved in interactions of the antigen with T-cells. 
Taking into account the stimulation of the cells used for the immunoprecipitation of 
proteins (i.e. pooling cells stimulated with Con A) from which membrane bound IgG 
was identified, it is possible that this stimulation led to the promotion of some 
unknown signalling functions. Unfortunately, attempts to elucidate the interaction of 
the proteins involved, perhaps as a complex protein, by BN-PAGE were unsuccessful, 
possibly because the method was not completely optimized or the proteins involved 
were not bound together in a complex of molecules, even when they could interact 
with each other. However, it is a useful technique that has so far never been applied in 
fish studies. The possibility of using 2D BN-PAGE to separate proteins has 
advantages over isoelectrofocusing (IEF) during proteomics analysis given the 
possibility for having a higher representation of native membrane proteins. Added to 
that is the possibly of having information about the protein complexes themselves 
(separated in 1D gels) and about protein subunits that interact in the complex (in the 
2D gels) (Reisinger & Eichacker, 2007). Results achieved with this technique for the 
separation of proteins in one dimension were successful, and indicate the possibility to 
using this method to help understand how the membrane proteins from fish 
leukocytes interact.  
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Based on results from the present chapter, it appears that mAb TcOm15 not 
only recognises part of a population of thymic cells, but also recognises other 
populations of leukocytes. However, even though the mAb does not help to 
differentiate cell populations it appears to be a potentially useful marker for examining 
the cytoskeleton activity of cells. This is proposed by the fact that mAb TcOm15 
detected proteins involved in the organisation of the cytoskeleton and also detected 
cells undertaking certain functions; this needs to be further investigated.  
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Chapter 5 Antigen Expression on Activated Cells 
5.1 Introduction 
The induction of lymphocyte activation by mitogens in vitro is a technique 
widely used to study the ability of lymphocytes to be stimulated non-specifically. These 
assays have been applied to fish lymphocyte populations to evaluate the ability of the 
mitogens to promote mitosis (Kaattari & Yui, 1987; Reitan & Thuvander, 1991; Wang 
et al., 1997; Siegl et al., 1998; Scharsack et al., 2000; Espelid, Steiro & Johansen, 2003; 
Gauthier et al., 2003, Morrison et al., 2004), to elucidate the genetic lineage of 
responsive populations (Araki et al., 2008), to promote the expression of specific genes 
(Pelegrin et al., 2001; Savan & Sakai, 2002; Blohm, Siegl & Kollner, 2003; MacKenzie, 
Planas & Goetz, 2003), and to understand mechanisms of lymphocyte activation 
(Ferriere et al., 1999). A significant finding from these studies was the ability of sIgM+ve 
and sIgM-ve lymphocytes from fish to activate in response to stimulation with B-cell 
and T-cell mitogens, respectively (Kehrer, Hannan & Raison, 1998; Blohm, Siegl & 
Koellner, 2003, Araki et al., 2008). 
The mixed leukocyte reaction (MLR) is another important assay that has been 
used to examine the participation of specific subpopulations of T-cells during non-self 
recognition of allogeneic histocompatibility complexes. (Caspi & Avtalion, 1984, 
Miller, Deuter & Clem, 1986; Meloni et al., 2006; Majji et al., 2009).  
Cellular activation is triggered by a variety of signal molecules from different 
biological and chemical origins such as proteins, carbohydrates, lipids and nucleic acids. 
Receptors on the surface of cells detect the signals of danger and initiate the 
mechanisms that promote the expression of molecules involved in cell activation.  An 
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example of proliferation of B cells after successful activation of the immunocompetent 
cell by a thymus-dependent antigen is illustrated in Figure 4.1. 
 
Figure 5.1 Diagram of the process of activation of B-cells by a thymic dependent 
antigen (from Mak & Saunders, 2006, page 219). 
 
 
This activation process involves a number of complex phenotypic modifications 
that occur sequentially. The ability to detect human activated cells by means of 
membrane markers (for examples see Figure 4.2) has been used to evaluate the efficacy 
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of vaccines against important diseases such as measles and HIV (Schnorr et al., 2001, 
Gurunathan et al., 2009). 
 
 
 
 
 
Figure 5.2  Example of markers for B-cells and T-regulatory-cells from human (images 
from www.biolegend.com; Nov, 2009).  
 
 
Markers on the surface of leukocytes change both qualitatively and 
quantitatively according the different stages of differentiation or stimulation (Mak & 
Saunders, 2006). It has been found in mice, for example, that the number and type of 
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molecules expressed correlate with specific states of differentiation, as shown in Figure 
4.3. The mechanisms of lymphocyte activation and expression of all markers during 
this activation are more and less understood for mammals, however, this is a relatively 
new field of research for teleost fish and the number of mAbs against membrane 
markers is still very limited. 
 
Figure 5.3  Markers for B-cells in mammals expressed through the maturation process 
(from Mak & Saunders, 2006, page 212). 
 
 
Mitogens are compounds that have either been synthesized or extracted from 
plants or bacteria, and they can non-specifically activate cells in a variety of different 
ways. Lectins are mitogens from plants that interact with particular carbohydrate 
                  Bone marrow             Periphery 
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moieties on membrane glycoproteins. Concanavalin-A (from Canavalia ensiformis), for 
example, is a mitogen for T-cells that has a mannose structure with an affinity for 
monosaccharides such as glucose and mannose. The phytohaemagglutinin from 
Phaseolus vulgaris (PHA) promotes the activation and proliferation of T-cells and binds 
to oligosaccharides such as galectins, while pokeweed mitogen (PWM), a lectin 
produced from Phytolaca americana induces activation and proliferation of B and T-cells, 
however the binding affinity has not been defined (Sharon & Lis, 2004). 
Other types of compounds with mitogenic properties are the phorbol esters (e.g. 
PMA). These are toxic compounds derived from plants that interact with protein 
kinase C (PKC) and they affect the activity of a number of enzymes, biosynthesis of 
proteins, DNA, and polyamides, and also affect cell differentiation processes and gene 
expression. Hyper-activation of PKC by phorbol has been used to trigger activation 
and proliferation of lymphocytes (B and T) in stimulation assays (Goel et al., 2007) as 
well as stimulation of fish macrophages (Nagelkerke et al., 1990). Polyriboinosinic 
polyribocytidylic acid (Poly I:C) is a synthetic double-stranded RNA that resembles 
double-stranded RNA present during viral infections, and is also used to stimulate 
macrophages. Lipolysaccharide (LPS) is a compound found on the outer membrane of 
Gram negative bacteria and it is able to initiate the activation and proliferation of B-
cells (Han et al., 2003).  
A different approach has been the use of various synthetic or naturally derived 
products from plants, animals, or bacteria to promote activation of the immune system 
in vivo. These substances have been used as immunostimulants to promote an immune 
response against infectious diseases in several fish species (Mulero et al., 1998; Sakai 
1999; Sealey & Gatlin III 2001, Cuesta et al., 2003 & 2007, Bricknell & Dalmo, 2005). 
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Some studies have demonstrated that the administration of these substances during 
feeding can improve the production of specific components of the immune response, 
for example antibody production (Thompson et al. 1993), chemotaxis (Galindo et al., 
2004), migration and phagocytosis (Mulero et al., 1998), or an increase in leukocyte 
numbers (Ogier et al., 1996). 
Activation of cellular immune components through the use of mitogens in the 
laboratory or immunostimulats in vivo could be useful in helping to understand which, 
how and when the molecules associated with activation and differentiation are 
expressed on the surface of fish cells. 
 
Aim:  
The aim of the present chapter was to examine the effects of different 
stimulators of leukocytes (in vitro and in vivo) on the expression of the TcOm15 antigen, 
and to evaluate the potential of this antigen as a cell marker. 
 
5.2 Material and methods  
The basic methodology for isolation and culture of leukocytes was previously 
described in Chapter 2. In the present chapter, modifications were made to these 
methods with respect to mitogen stimulation and evaluation. Mitogen stimulation was 
promoted using different doses selected to obtain the optimum response in assays and 
selection was based on related literature available (Caspi et al., 1985, Lopresto, Kendall, 
& Burnett, 1994; Passer et al., 1996; Siegl et al., 1998; Espelid, Steiro & Johansen, 2003). 
The experiments will be described indicating the methodology employed. Data for 
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flow cytometry (FCM) were analysed with the WinMDI 2.9 programme from Joe 
Trotter, Scripps Research Institute, La Jolla, CA.  
5.2.1 Detection of TcOm15+ cells on multiple way HCA assays by 
FCM 
5.2.1.1     Evaluation of one dose effects of Con A/LPS on mHCA assays 
Isolated peripheral blood leukocytes from three fish were prepared, as described 
in Section 2.3.1, and pooled together and prepared for culture according to the method 
in Section 2.3.2. Two different mitogens were used in separate cultures to enhance the 
mHCA. Con A from Canavalia ensiformis, type IV-S (Sigma-Aldrich) was added at a final 
concentration of 30 µgml-1 and LPS from E. coli (055:B5) (Sigma-Aldrich) at a final 
concentration of 100 µgml-1. Cells from treated cultures were recovered 5 days later 
and stained with mAb TcOm15 to be evaluated by FCM according to Section 2.2.4. 
5.2.1.2     Evaluation of TcOm15+ cells with three doses of Con A/LPS on 
HCA assays 
The PBLs from five fish were pooled together and prepared for culture 
according to methodology outlined in Sections 2.2.1 and 2.2.2.  Mitogens Con A from 
Canavalia ensiformis, type IV-S and LPS from E. coli (055:B5) were added separately at 
three different final concentrations of 15 µml-1, 30 µml-1, and 45 µml-1. Cultures with 
mitogens were prepared in two batches of three replicate samples for analysis on Day 1 
and Day 6 post-stimulation. Staining with mAb TcOm15 was evaluated by FCM on 
these days.  
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5.2.2 Detection of TcOm15+ activated PBLs from individual fish  
5.2.2.1     Evaluation by FCM of TcOm15+ PBLs with one dose of Con 
A/LPS 
Three fish were bled and leukocytes isolated as described in Section 2.3.1. Cells 
were cultured separately according to Section 2.3.2. Two different mitogens were used 
by separate for stimulation of the leukocytes; Con A from Canavalia ensiformis, type IV-S 
was added to obtain a final concentration of 30 µgml-1, and a final concentration of 100 
µgml-1 with LPS from E. coli (055:B5). Samples were prepared and evaluated by FCM 5 
days later according to Section 2.2.4. 
5.2.2.2     Evaluation by FCM and WB of TcOm15+ PBLs with six different 
mitogens 
Leukocytes from 4 fish were isolated as described in Section 2.3.1, and cells 
were cultured separately according to Section 2.3.2. Six different mitogens were used 
individually to promote activation. Accordingly, separated batches with mitogens were 
prepared as follows: Con A from Canavalia ensiformis, type IV-S was added at a final 
concentration of 30 µgml-1 and 90 µgml-1, LPS from E. coli (055:B5) at a final 
concentration of 100 µgml-1, PMA (Sigma-Aldrich) at a final concentration of 5 ng, 
PHA-P (Sigma-Aldrich) at 20 µgml-1, PWM (Sigma-Aldrich) at 10 µgml-1 and Poly I:C 
(Sigma-Aldrich) at 100 µgml-1. Samples were evaluated by FCM 3 days later according 
to Section 2.2.4.  
A second experiment was performed under the same conditions with 6 fish and 
samples evaluated on Day 1 and Day 3 post-stimulation. Cells were fixed with Cytofix 
solution (BD Biosciences) before staining. A batch of cells from these cultures was also 
prepared for analysis by SDS-PAGE and Western blot (Section 3.2.4). 
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5.2.3 TcOm15 staining of activated PBLs by IIF 
5.2.3.1     Confocal microscopy evaluation of TcOm15+ PBLs activated with 
mitogens 
Peripheral blood leukocytes from 4 fish were isolated as described in Section 
2.2.1, and cells were cultured according to Section 2.2.2 in 8 wells LabTek chamber 
glass slides (Nunc, Fisher Scientific, UK). Three different mitogens were used to 
promote activation by separate. Con A from Canavalia ensiformis, type IV-S was added at 
a final concentration of 90 µg ml-1, LPS from E. coli (055:B5) at a final concentration of 
100 µg ml-1, and PMA at 5 ng ml-1. Samples were evaluated by confocal microscopy 
after 20 min, and 1 hour post- stimulation.  
Slides were washed two times with 200 µl of PBS/0.5 % BSA by inverting to 
remove the liquid. First they were incubated with 200 µl of mAb TcOm15 at 10 µg ml-1 
in PBS/BSA for 30 min and then washed twice with this buffer. A further incubation 
of 30 min was performed with a second antibody anti-mouse conjugated with Texas 
Red (20 µlml-1 of PBS/BSA) and again washed twice as above. Subsequently, the slides 
were incubated with a solution to permeabilize and fix the cells (i.e. with 2 % 
paraformaldehyde (Sigma-Aldrich), 3 % sucrose (Sigma-Aldrich), 0.5 % Triton X-100 
(Sigma-Aldrich), and 2.5 % of methanolic solution of Alexa Fluor 488 Phalloidin 
(Invitrogen) in PBS (pH 7.4) for 12 min). Finally, Vector mounting shield with DAPI 
(stain for DNA) was added and slides were maintained in the dark until observation 
using a Leica TCS SP2 AOBS confocal scanning laser microscope. A series of twenty 
sections through the image was acquired and digitalised from two randomly selected 
fields in each sample (4 fish x 4 treatments x 2 times post stimulation). The 20 images 
were taken from top to bottom, using the slide surface as point of reference to start the 
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series. A total of 20 µm at the zy position were obtained for the spatial image series. 
Relative mean intensity was evaluated in the collapsed 20 series section for every series 
scanned using the programme ImageJ (http://rsbweb.nih.gov/ij/). 
5.2.4 Detection of TcOm15+ leukocytes from different organs  
5.2.4.1     Evaluation by FCM and WB of TcOm15+ leukocytes isolated from 
four organs and stimulated with mitogens 
Leukocytes from 4 fish were isolated from thymus, spleen, head kidney and 
peripheral blood as described in Section 3.2.1, and cells were cultured separately 
according to Section 3.2.2. Mitogens were added as follows: (1) PBLs were stimulated 
with PWM at a final concentration of 10 µgml-1; (2) Thymus leukocytes were 
stimulated with 20 µgml-1 of PHA-P; (3) Spleen leukocytes were stimulated with 100 
µgml-1 of LPS from E. coli (055:B5); (4) Head kidney leukocytes were stimulated with 5 
ngml-1 of PMA. 
Stimulated cells were fixed with Cytofix solution (BD Biosciences) on Day 1, 
Day 3 and Day 6 post-stimulation and evaluated by FCM according to Section 3.2.4. 
Stimulated cells were also harvested on Day 6 for analysis by SDS-PAGE and 
Western blot. The cells collected were washed twice with PBS. The cells were lysed for 
IP which was performed to isolate proteins binding with mAb TCOm15 according to 
Section 3.2.5. Electrophoresis and Western blot was carried out to analyze differences 
in protein expression and antibody binding between treatments according to Section 
3.2.4 and 3.2.5. 
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5.2.4.2     Evaluation of TcOM15+ head kidney leukocytes stimulated with 
mitogens 
Leukocytes from the head kidney of one fish were isolated as described in 
Section 2.3.1, and cells cultured according to Section 2.3.2. Three different mitogens 
were utilised to promote activation. Con A from Canavalia ensiformis, type IV-S was 
added at three final concentrations of 15 µgml-1, 30 µgml-1 and 45 µgml-1, LPS from E. 
coli (055:B5) at two final concentrations of 60 µgml-1 and 100 µgml-1 and Poly I:C at a 
final concentration of 100 µgml-1. Samples were evaluated by FCM on Days 3 and 6 
post-stimulation according to Section 2.2.4. 
5.2.5  Effects of immunostimulation in vivo with Ergosan and β-
glucan on detection of TcOm15+ cells.  
The expression of the protein detected by mAb15 on Rainbow Trout 
leukocytes, was examined after feeding the fish with two different immunostimulant 
diets. A total of 90 fish were randomly separated into 6 experimental groups (15 fish 
tank-1). Commercial pellets for trout were moistened with gelatine (SuperCook, UK) (at 
8 g l-1 of water) as a binder and powdered immunostimulants were added to the pellets 
at the concentrations indicated below, before allowing the treated pellets to air dry. 
Two groups of fish receive a diet of Ergosan (Laminaria digitata 99 % and Ascophillum 
nodosum 1 %, from Schering-Plough Aquaculture, UK), using a dose of 0.5 % of diet 
weight according to the manufacturer´s recommendations. Another two groups 
received a diet with 10 gkg-1 β-glucan (from Saccharomyces cerevisiae) prepared using 
Biolex tablets (Lieber, Denmark) and another two groups were fed with the same 
commercial trout diet without immunostimulants as a control group. Fish were fed 
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with the diets for 15 days feeding twice daily to satiation throughout the experiment 
period.  
Three fish were sampled from each experimental group before treatment (i.e. 
D0). After starting the treatment, three fish from each tank i.e. six fish per treatment 
and six control fish (18 fish in total) were sampled on Days 3, 7, and 14 after feeding 
with the experimental diets. Sampled fish were anaesthetized with benzocaine 10 % 
w/v in ethanol by immersion, bled from the caudal vein and sacrificed by over-
anaesthetizing them. Leukocytes from thymus, spleen, head kidney and peripheral 
blood were isolated from each sampled fish according to the methods described in 
Section 2.3.1. Isolated leukocytes were fixed and preserved in the fridge (4oC) and the 
next day stained with mAb TcOm15 for FCM according to Section 2.2.4. 
5.3 Results 
5.3.1 Detection of TcOm15+ cells on multiple way HCA assays by 
FCM 
5.3.1.1     Evaluation of one dose effects of Con A/LPS on HCA assays 
Data were collected from the area gated in R1 or RLymph, corresponding to 
the lymphocyte region as shown in Figure 4.4. When pooled PBLs were cultured in a 
mHCA small differences could be seen in the RLymph region between the different 
treatments (Figure 4.5 a & b). The basal mHCA reaction showed that 27.7 ±3.6 % of 
cells gated in the RLymph region of the scatter plot from 10,000 cells counted (Figure 
4.5). Of these, 72.0 ±0.5 % were positively stained with mAb TcOm15. For the cells 
treated with LPS, a total of 24.2 ±8.8 % of cells were gated and of these 74.5 ±0.9 % 
were positively stained with the mAb, while for the Con A treated cells, a total of 24.7 
±4.0 % were gated in the RLymph region and 75.5 ±0.8 % of these were positive with 
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the mAb. An increase in the total number of positive cells (i.e. gated and not gated) was 
detected in the presence of mitogens (32.1 ±2.5 in the basal reaction, 38.8 ±1.2 plus 
LPS and 40.8 ±0.2 plus Con A).Thus there was a tendency to detect higher numbers of 
TcOm15+ cells in the mHCA treated with LPS and Con A compared to the basal 
reaction (Figure 4.5 b). A slight increase was also noted in the number of positives cells 
inside the RLymph gate when the mHCA with the mitogens (72.0 ±0.5 in the basal 
reaction, 74.5 ±0.9 with LPS and 75.5 ±0.8 with Con A).  
 
 
Figure 5.4 Flow cytometry analysis of rainbow trout leukocytes from mHCA culture 
after 5 days of culture.  Example of a dot plot showing the R1 or RLymph region, 
red dots indicate gated cells in R1, and blue dots indicate gated cells in R2; green 
dots indicate positive cells.  
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a) 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
Figure 5.5 Flow cytometry analysis of rainbow trout leukocytes from mHCA culture 
after 5 days of culture. (a) Percentage (± s.d.) of total gated cells (positive in purple 
and negative in blue) in lymphocyte region (RLymph.), and positive cells from the 
total number of cells counted (10,000) in green, (b) values are mean percentages (± 
s.d.) of triplicate sample cultures from one mHCA assay. 
 
5.3.1.2     Evaluation of TcOm15+ cells with three doses of Con A/LPS on 
HCA assays  
Pooled leukocytes (from five fish) were stimulated in the mHCA and the basal 
stimulation response was enhanced with Con A or LPS. Data were collected from the 
gated R1 region (RLymphocytes), and the R3 region (Total positive cells). For R1, a 
mark (M1) was set during analysis on the histograms to obtain the percentage of 
positive cells inside the gate and, two more marks were set (M2 and M3) due to the 
detection of two groups of cells showing different intensities between treatments 
(example for data analysis, Figure 4.6). 
Samples of mHCA stimulated cells after 1 day of culture with Con A and LPS 
showed a reduction in the population of total positive cells that was inversely 
 mHCA mHCA+LPS mHCA+Con A 
% Gated in RLymph 27.7 ± 3.6 24.2 ± 8.8 24.7 ± 4.0  
% Positives in RLymph 72.0 ± 0.5 74.5 ± 0.9 75.5 ± 0.8  
% Total positives 32.1 ± 2.5 38.8 ± 1.2 40.8 ± 0.2  
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proportional to the amount of mitogen added when compared to control cells (Figure 
4.7 & Table 4.1). Conversely, a slight increase was observed in the total number of cells 
gated in RLymph with respect to the control; however the number of positive cells 
inside the gate was inversely proportional to the dose of Con A added. The number of 
cells in M2 was also inversely proportional to the dose of mitogen used, with Con A 
appearing to have a greater effect than LPS. A decrease in the intensity of fluorescence 
was observed in the mitogen-enhaced reactions when compared to the basal reaction 
(Figure 4.7 & Table 4.1). For the cells in mHCA enhanced with mitogens in M3, lower 
intensities than the control or basal reaction were observed (Figure 4.7 & Table 4.1). 
After six days of culture, a slight increase in the percentage of total positive cells 
was observed in the mHCA enhanced with Con A compared to levels seen after only 
three days of culture (Figure 4.8 & Table 4.2). However, when compared to the control 
for same day (i.e. Day 6), the reduction was proportional to the dose of mitogen used, 
reaching a 50 % reduction of labelled cells for those cells treated with 45 μgml-1 LPS.  
The cells gated in the RLymph region stimulated with either Con A or LPS, showed a 
decrease of positive cells in relation to the concentration of Con A or LPS used. At 
lower concentrations of Con A or LPS, a higher number of positive cells were gated in 
the RLymph, while an inverse was observed for the total number of cells gated inside 
RLymph region (i.e. negative + positive cells), showing major detection occurring with 
cells stimulated with 45 μg ml-1 LPS compared to control cells (Figure 4.8). When 
histograms comparing the dose of Con A used after 1 day of culture were analysed, it 
was possible to observe a migration of peaks in marks M2 and M3; the higher the dose 
used the lower the intensity of fluorescence seen, as shown in Figure 4.9. After 6 days 
of stimulation with Con A, the intensities were comparable to the controls indicating 
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an up regulation of the TcOm15+ molecule (Figure 4.9). The number of cells in mark 
M3 had doubled with 45 μgml-1 of Con A indicating a increased detection of positive 
cells (Figure 4.9). For histograms of LPS stimulated cells histograms showed a slight 
down regulation of the TcOm15+ expression and slight increase of cells after 6 days of 
stimulation (Figure 4.10). 
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Figure 5.6 Example window in the WinMDI program to analyse data obtained by flow cytometry for mHCA experiments. a) gate R1 or 
RLymphocyte, b) R3 or total positive TcOm15 cells, c) histogram in green showing total positive cells showing mark 1 (M1) to 
determine the number of gated positive cells, and d) histogram in red showing mark 1 (M1) to determine the number of gated positive 
cells, and mark 2 (M2) and mark 3 (M3) to determine percentage of cells with two different peaks of intensity inside R1. 
 117 
 
 
Figure 5.7 Flow cytometry analysis of rainbow trout PBLs from mHCA after culture 
for 1 days. Percentages of total positive TcOm15 cells (positives and negatives) from 
the total counted (10,000), percentage of gated cells in RLymph (negatives in dark 
blue and positives in green), (One assay with 5 fish pooled PBLs). 
 
 
 
Table 5.1 Flow cytometry analysis of rainbow trout PBLs from mHCA after cultured 
for 1 day. 
1 Day % Total 
% Gated from total in 
RLymph 
M2 in RLymph M3 in RLymph 
 TcOm15+ Negatives TcOm15+ % in Mark 
Intensity 
Gmean 
% in 
Mark 
Intensity 
Gmean 
Con A15 34.4 ±1.0 24.4 ±0.6 25.9 ±0.7 27.5 ±1.8 44.7 ±2.5 35.1 ±2.8 8.6 ±3.2 
Con A30 21.9 ±0.8 42.3 ±0.4 12.3 ±0.1 16.8 ±2.0 36.0 ±1.0 64.4 ±1.9 4.4 ±0.1 
Con A45 17.0 ±1.3 47.9 ±0.9 9.6 ±0.9 12.7 ±3.1 32.0 ±8.7 51.5 ±25.8 4.0 ±1.7 
LPS15 31.5 ±0.8 26.8 ±0.6 23.5 ±1.2 21.8 ±3.5 47.7 ±2.1 40.1 ±0.6 8.7 ±0.1 
LPS30 29.0 ±0.5 32.5 ±3.2 20.2 ±0.3 22.2 ±1.3 45.6 ±2.0 48.6 ±2.7 7.1 ±0.4 
LPS45 27.1 ±0.5 33.5 ±0.4 17.4 ±1.0 21.3 ±1.0 43.2 ±0.7 50.5 ±2.2 6.6 ±0.4 
Basal 
reaction 
37.2 ±0.5 20.4 ±0.6 28.7 ±0.0 17.6 ±0.7 56.4 ±0.4 43.3 ±1.3 12.0 ±0.1 
Mean percentages (± s.d.) obtained for total positives cells (R3) and gated cells in Rlymph. 
Geometric mean (± s.d.) for records of intensity fluorescence in M2 and M3 are shown. 
Data obtained from duplicated sample wells and 10,000 events analysed from mHCA 
without mitogen as control or basal reaction, mHCA stimulated separately with three 
different doses of Con A (15, 30 and 45µg/ml) and mHCA stimulated with three different 
doses of LPS (15, 30 and 45µg/ml), (One assay with 5 fish pooled PBLs). 
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Figure 5.8 Flow cytometry analysis of rainbow trout PBLs from mHCA after cultured 
for 6 days. Percentages of total positive TcOm15 cells (positives and negatives) 
from the total counted (10,000), percentage of gated cells in RLymph (negatives in 
dark blue and positives in green), (One assay with 5 fish pooled PBLs).  
 
 
 
Table 5.2. Flow cytometry analysis of rainbow trout PBLs from mHCA after cultured 
for 6 days. 
6 Days % Total 
% Gated from total in 
RLymph 
M2 in RLymph M3 in RLymph 
 TcOm15+ Negatives TcOm15+ 
% in 
Mark 
Intensity 
Gmean 
% in 
Mark 
Intensity 
Gmean 
Con A15 36.6 ±1.7 24.9 ±0.9 27.3 ±0.5 11.7 ±0.4 62.8 ±4.2 55.6 ±0.3 12.4 ± 0.4 
Con A30 32.9 ±0.9 28.3 ±0.1 25.3 ±0.6 11.8 ±1.2 51.0 ±4.0 52.0 ±0.1 10.8 ±0.3 
Con A45 30.4 ±2.2 33.3 ±1.5 23.6 ±1.3 10.5 ±2.6 47.3 ±3.1 64.0 ±11.1 8.9 ±0.7 
LPS15 26.8 ±2.3 34.6 ±0.2 19.2 ±0.2 13.7 ±0.2 56.4 ±2.2 66.6 ±1.6 7.3 ±0.4 
LPS30 22.2 ±1.0 35.9 ±2.5 14.3 ±0.3 18.4 ±3.8 56.2 ±1.1 63.0 ±4.9 6.3 ±0.0 
LPS45 17.1 ±0.4 43.5 ±0.6 9.8 ±1.6 12.5 ±0.4 44.5 ±4.6 70.7 ±2.0 5.1 ±0.5 
Basal 
reaction 
38.3 ±1.6 19.7 ±0.8 28.7 ±1.1 16.8 ±1.0 72.3 ±2.9 49.4 ±1.6 13.4 ±0.7 
Mean percentages (± s.d.) obtained for total positives cells (R3) and gated cells in RLymph. 
Geometric mean (± s.d.) for records of intensity fluorescence in M2 and M3 are shown. 
Data obtained from duplicated sample wells and 10,000 events analysed from mHCA 
without mitogen as control or basal reaction, mHCA stimulated separately with three 
different doses of Con A (15, 30 and 45µg/ml) and mHCA stimulated with three different 
doses of LPS (15, 30 and 45µg/ml), (One assay with 5 fish pooled PBLs). 
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Figure 5.9 Flow cytometry analysis of rainbow trout PBLs from mHCA after culture for 1 and 6 days. Histograms showing data from 
10,000 events analysed in gate RLymph and during stimulation with Con A. a) shows data from cells stained with 2nd antibody 
without 1st antibody to evaluate background, b) data comparing the different doses of mitogen at day 1 indicating increase in the 
number of unlabeled cells and migration of events to a lower intensity when comparing to control (black line) with a blue arrow, and 
c) comparison of three doses after 6 days of culture (blue arrow indicates an increase in intensity and numbers compared to 
controls). In d), e) and f) histograms comparing single doses over time are shown with arrows indicating down regulation in the first 
day and up regulation for the highest dose on day six, (One assay with 5 fish pooled PBLs). 
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Figure 5.10 Flow cytometry analysis of rainbow trout leukocytes from mHCA cultured for 1 and 6 days. Histograms showing data from 
10,000 events analysed in gate RLymphocytes and their intensity during stimulation with LPS (a) data from cells stained with 2nd 
antibody without 1st antibody to evaluate background; (b) data comparing different doses of LPS after day 1, and (c) comparison of 
three doses after 6 days of culture with the blue arrow indicating slight decreased detection of labelled cells of events. In d), e) and f) 
histograms with single doses over time are compared, the orange arrow shows an increased number of unlabelled cells on the first 
day compared to day six, (One assay with 5 fish pooled PBLs). 
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5.3.2 Detection of TcOm15+ activated PBLs from individual fish by 
FCM 
5.3.2.1     Evaluation of TcOm15+ PBLs with one dose of Con A/LPS 
Leukocytes from peripheral blood of three fish were stimulated separately with 
Con A (30 µg ml-1) or LPS (100 µg ml-1). Cells were stained with mAb TcOm15 on day 
5 after stimulation and the level of fluorescing cells determined in gate R1 (RLymph), 
and R3 (Total positive cells). For R1, the mark (M1) was used to obtain the percentage 
of cells fluorescing inside the gate (Figure 4.11). 
The mean percentage of labelled cells from the three fish evaluated showed an 
increase of 4 % in cells stimulated with 100 µg ml-1 LPS and 6 % for leukocytes 
stimulated with 30 µg ml-1 Con A compared to unstimulated cells in which 32 % of 
cells were stained (Table 4.3). 
By separate analysis of the three fish evaluated, an increase of approximately 8 
% and 10 % was observed in positive cells gated in the RLymph region following 
stimulation with LPS or Con A, respectively, for two of the three fish (Figure 4.12). 
One fish did not respond to stimulation with either LPS or Con A. For Fish 2, an 
increase in the number of labelled cells inside the gate in the RLymph region of 5 % 
and 10 % approximately was observed for cells stimulated with LPS and Con A 
respectively. For Fish 3, an increase in the percentage of cells labelled inside gate 
RLymph of 6 % was detected for leukocytes stimulated with LPS, while those 
stimulated with Con A showed a lower percentage of gated and fluorescent cells inside 
the gate compared to the control. 
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Figure 5.11 Example window in WinMDI program to analyse data from stimulation experiments with Con A and LPS in single fish 
obtained by flow cytometry. Gate R1 or RLymphocyte in a), R3 (total positive events) is shown in b) and c), mark 1 (M1) to obtain 
the number of cells positives inside gate RLymph or R1. 
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Table 5.3 Percentage of leukocytes of three rainbow trout labelled with mAb TcOm15 
after culturing for five days with either LPS or Con A. Data are shown as mean 
percentages (± s.d.). 
 
 
% of Total 
TcOm15+ 
% Gated in RLymph 
  Negatives Positives 
Control 32.2 ± 14.1 2.3 ± 2.3 14.7 ± 6.2 
LPS 36.1 ± 18.6 3.0 ± 1.5 17.1 ± 8.2 
Con A 38.3 ± 17.8 2.4 ± 1.3 14.5 ± 5.3 
 
 
 
Figure 5.12 Percentages of PBLs from rainbow trout cultured without mitogen as 
control and stimulated with Con A (30 µg/ml) and LPS (100 µg/ml). Percentages of 
total positive cells are shown in light colour and percentage of gated cells in 
RLymph, negatives in dark colour and positives in light colour. Data obtained after 
5 days of stimulation from duplicated samples from three fish. 
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5.3.2.2     Evaluation by FCM and WB of TcOm15+ PBLs with six different 
mitogens 
Six different stimulants were added separately to PBLs from 4 fish: Con A45 
(45 μgml-1) and Con A90 (90 μgml-1) to promote stimulation of T-cells; LPS to 
stimulate B-cells; PMA to stimulate granulocytes; PHA for T-cells; PWM for B-cells 
and Poly I:C as a monocyte stimulator. It was found that gated cells in the RLymph 
region increased in number when stimulated with PWM by 70 % compared to the 
control with 55 % gated cells. In contrast, PMA reduced the number of gated cells to 
18 % (Figure 4.13 & Figure 4.14). Cells stained with the mAb inside the gate RLymph 
had a tendency to increase under mitogenic stimulation, increasing by more than 2 % 
for LPS, PHA and PWM when compared to the labelled cells in gate RLymph from 
control wells with a value of 21 %. However, the number of labelled cells in the gate 
decreased to 11 % when stimulated with Poly I:C and almost disappeared in the 
presence of PMA to 1 %. From the total number of labelled (or fluorescing) cells, the 
controls showed a mean of 21 % (Figure 4.14). This mean number was increased by 
approximately 37 % with PWM stimulation and decreased by up to 15 % in cells 
stimulated with PMA. 
It was noted during analysis that the data from the four fish showed differences 
in their response to the various stimulants (Figure 4.14). However, even though the 
total number of gated cells in RLymph region and the gated positives varied, similar 
patterns of reaction were seen between fish according to the mitogen used (see Figure 
4.14). The histograms for percentage of TcOm15+ gated cells, indicated that the values 
were similar between lower responder fish and higher responder fish to stimulation see 
TcOm15+ in RLymph in Figure 4.14.  
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Figure 5.13 Flow cytometry analysis of rainbow trout leukocytes from peripheral blood 
cultured with six different mitogens for 3 days. Percentages of gated cells (± s. d.) 
in RLymph were positives are in purple and negatives in dark blue, and total 
TcOm15+ cells (± s. d.) in green from 10,000 events (n=4). 
 
 
However, stimulation was detected (increase in the number of gated cells 
compared to the control cells) for PWM stimulated cells, inhibition (decrease in the 
number of gated cells in RLymph compared to the control cells) with Poly I:C, up 
regulation (increase in the Gmean intensity of fluorescence compared to the control) 
for LPS stimulation, and down regulation (decrease in the Gmean of intensity 
compared to the control) in PMA stimulated cells. These patterns of stimulation were 
detected for all four fish (Figure 4.15). 
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Figure 5.14 Flow cytometry analysis for leukocytes from peripheral blood cultured separately for 3 days with 6 mitogens from four rainbow 
trout.  Data are shown in separated graphs to show for every fish the pattern of detection of negative cells gated in RLymph, TcOm15+ 
cells gated cells in RLymph, and total TcOm15+ cells. 
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Figure 5.15 Flow cytometry analysis of rainbow trout leukocytes from peripheral blood 
cultured for 3 days in gate RLymph. (a) example of one fish (b) principal features in 
the response to different mitogens for four separate fish analysed: yellow dots 
increased detection with PWM; blue dots up regulation with LPS; orange dots 
decreased detection with poly I:C, and red dots down regulation with PMA. 
Positives from 101 of fluorescence intensity (x axis). 
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A second experiment was performed under the same conditions with PBLs 
from six fish. However, due to an error in the methodology with samples for flow 
cytometry (i.e. they were fixed with formalin before staining), no data were obtained. 
However a batch of cells from one fish (not fixed) were treated for protein extraction, 
and SDS-PAGE and Western blot was performed. No differences were found between 
treatments by mitogens after six days by SDS-PAGE and Western blot analysis. 
Protein bands were weakly detected by mAb TcOm15 at 250, 160 and 105 kDa (Figure 
4.17b). 
 
Figure 5.16 a) SDS-PAGE for protein samples extracted from PBLs from one rainbow 
trout cultured for three days with (1) Con A45; (2) Con A90; (3) LPS; (4) PMA; (5) 
PHA; (6) PWM; (7) Poly I:C; (8) control; b)Western blot with mAb TcOm15.  
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5.3.3 TcOm15 staining of activated PBLs by IIF 
Leukocytes cultured in the slide chambers covered with poly-L-lysine (i.e. PBLs 
from 4 fish) were stimulated either with Con A, LPS or PMA. A sequence of twenty 
images was randomly taken from two sites on every slide (analysed by the ImageJ 
program). The mean intensity was obtained for every field from four fish, four 
treatments (including control), at two different times (Example Figure 4.18). 
 
 
Figure 5.17 Example of collapsed 20 series image of confocal microscopy analysed 
with ImageJ programme for mean intensity of Texas red conjugate binding to mAb 
TcOm15. MAb TcOm15 in red, nuclei in blue  and F-actin in green. 
 
 
From the confocal analysis a slight increase in the mean intensity for the 
leukocytes treated with mitogens was detected after 20 min when compared with the 
control (see Figure 19 & Table 4.4). For cultures 24 hours old, no differences were 
observed in the intensity detected for Texas red (Figure 4.19). In order to relate mean 
intensity of nuclei fluorescence with DAPI and mean intensity of fluorescence detected 
for Texas red conjugate binding to mAb TcOm15 a ratio was calculated. The results 
indicated that a positive trend in the relation was observed only for ConA (0.09 ±0.03) 
after 20 minutes of stimulation when compared to the control (0.04 ±0.02), a slight 
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negative trend was registered after 24 hours for samples treated with LPS (0.05 ±0.02) 
compared to the control (0.08 ±0.06) (Table 4.4). 
 
Figure 5.18 Mean intensity fluorescence detected for TcOm15 + rainbow trout PBLs 
with Texas red conjugated second antibody stimulated with 3 different mitogens 
and control. Confocal images were analysed for Texas red channel after 20 min, and 
24, 72 and 124 h of culture. Data were obtained from collapsed 20 series of images 
every treatment and time, (n=4). 
 
 
 
Table 5.4 Mean intensity of fluorescence detection for Texas red channel and relation 
of texas red respect to the mean fluorescence of DAPI as control detected on 
TcOm15+ rainbow trout PBLs.  
 20 min 24 hrs 
Control 
Texas red 1.01 ± 2.63 2.45 ± 5.65 
TR/DAPI 0.04 ± 0.02 0.08 ± 0.06 
ConA 
Texas red 1.43 ± 3.77 2.69 ± 5.03 
TR/DAPI 0.09 ± 0.03* 0.06 ± 0.01 
LPS 
Texas red 1.26 ± 3.32 1.68 ± 3.36 
TR/DAPI 0.05 ± 0.02 0.05 ± 0.02 
PMA 
Texas red 1.51 ± 3.50 2.09 ± 5.02 
TR/DAPI 0.05 ± 0.02 0.07 ± 0.06 
Data were obtained from confocal images from stimulation assays with 3 different mitogens. 
Samples were analysed after 20 min, 24, 72 and 124 h, and data obtained from a 20 series 
colapsed image for every treatment and time, (n=4). 
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5.3.4 Detection of TcOm15+ leukocytes from different organs  
5.3.4.1     Evaluation by FCM and WB of TcOm15+ leukocytes isolated from 
four organs and stimulated with mitogens 
Leukocytes were isolated from different organs of rainbow trout and cultured 
with one of four different mitogens. PBLs were stimulated with PWM, thymus 
leukocytes with PHA, spleen leukocytes with LPS and head kidney with PMA and 
cultured for 1, 3 and 6 days with the mitogens. Cultures were stained with mAb 
TcOm15 and then analysed by FCM.  
Data were obtained from the gated cells in the RLymph and RGran regions of 
the dot plot. PBLs were seen to have undergone stimulation indicated by the increase 
in the number of gated cells (48 % - 53 %) when compared with the unstimulated cells 
(25 % - 48 %). Stimulation with the mitogen over time, in contrast led to a decrease in 
the number of thymus leukocytes seen in the RLymph gate. Overall, the highest 
number of cells was seen with the control cells at Day 1 (62 %) and the lowest with 
thymus leukocytes at Day 6 with PHA (i.e. 31 %). Spleen and head kidney leukocytes 
also showed some inhibition with mitogen stimulation over time (Figure 4.20). Gated 
cells in the granulocyte region were very low for PBL, thymus and spleen populations 
of leukocytes (a maximum of approximately 5 %) but higher with head kidney 
leukocytes (i.e. 25 %). However, the levels of gated cells appeared similar with 
stimulated cells from each organ over the course of the experiment (Figure 4.20). 
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Figure 5.19 Percentages of gated leukocytes from peripheral blood (PB), thymus 
(THL), spleen (SPL) and head kidney (HKL) of rainbow trout analysed by flow 
cytometry in RLymph and RGran. Analysis was performed on day 1, 3 and 6 of 
culture with 4 different mitogens. Controls are indicated by lighter colour and 
stimulated cells by the darker, (n=4). 
 
 
 
The total number of cells labeled with mAb TcOm15 in PBL and thymus 
leukocytes samples had a tendency to increase under mitogen stimulation and over 
time (dark red and dark blue bars in Figure 4.21), while no evident increase of staining 
occurred with mAb TcOm15 with spleen and head kidney leukocytes with mitogen 
stimulation over the course of the trial (dark brown and dark orange in Figure 4.21). 
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Figure 5.20 Percentage of total TcOm15+ cells from trout leukocytes from 4 organs 
cultured with 4 mitogens during 1, 3, and 6 days. Percentages for leukocytes from 
peripheral blood (PBL) are shown in dark red, thymus (THL) in dark blue, spleen 
(SPL) in brown, and head kidney (HKL) in orange, (n=4). 
 
 
A set of samples, cultured under the same conditions for 6 days, were lysed, and 
immunoprecipitated with mAb TcOm15. The proteins that were obtained were 
analysed by SDS-PAGE and Western blotting. No differences were observed between 
leukocytes treated with the mitogens and untreated cells from the different organs. 
Proteins bands observed in SDS-PAGE and Western blotting from whole lysates and 
IP were comparable between treated and untreated cells for all organs (Figure 4.22). 
Faint bands were detected at 250 kDa on the Western blot by mAb TcOm15 (Figure 
4.22 c). 
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Figure 5.21 SDS-PAGE of a) whole lysates from rainbow trout leukocytes, b) for IP, 
and c) Western blot of IP with mAb TcOm15. Protein samples were extracted from 
leukocytes obteinaed from a single fish cultured for 6 days. Lanes (1) PBL with 
PWM, and (2) PBL control; (3) thymus leukocytes with PHA, and (4) thymus 
leukocytes control; (5) spleen leukocytes with LPS, and (6) spleen leukocytes 
control; (7) head kidney with PMA, and (8) head kidney leukocyte control. 
 135 
 
5.3.4.2     Evaluation by FCM of TcOM15+ head kidney leukocytes 
stimulated with mitogens 
In order to determine if activated granulocytes expressed the protein detected 
by mAb TcOm15, head kidney leukocytes were stimulated with Con A, LPS and Poly 
I:C and data were acquired by flow cytometry for cells cultured for 3 and 6 days. Cells 
were gated in three main groups for analysis, R1 (or RLymph), the region for 
granulocytes R2 (RGran), and a R3 for small precursor cells (RPrecursor) (Figure 4.26). 
Few leukocytes were gated (negatives + positives) in RLymph region, but higher 
levels of gated cells were observed in samples stimulated with Poly I:C (8 %) and LPS 
(9 %), while the samples stimulated with Con A for three days  showed approximately 
4 % of cells gated in this region (Figure 4.27, 3 days). The numbers of labelled cells 
inside the RLymph gate were small. From these, the higher numbers of positives cells 
were obtained with LPS and Poly I:C stimulation (7 % and 4 % respectively), while 
Con A stimulated cells were labelled at about 2 %, with no differences between the 
concentrations of Con A used. On the other hand granulocytes represented the highest 
numbers of gated cells. Following stimulation with Con A, the number of total cells in 
gate RGran increased according to the dose (about 2 % between Con A 
concentrations). Gated granulocytes stimulated with poly I:C showed a high percentage 
of 66 % when compared to the cells stimulated with Con A or LPS. It was noticed that 
the numbers of cells in region 3, where precursors and debris occur, were highly 
labelled at about 22 % for Con A15 (15 µg/ml), while stimulation with LPS100 (100 
µg/ml) gave approximately 5 %. The number of cells observed in R3 appeared to 
change according to the dose of Con A used, with a higher percentage of gated cells at 
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the lowest concentration used. The total number of fluorescent cells was more or less 
maintained between 20 and 30 % (Figure 4.27, 3 days). 
After six days of culturing head kidney leukocytes with Con A, there was a low 
level of gated cells in RLymph (0.2 – 1.4 %), while percentages for cells in this region 
stimulated with LPS and Poly I:C were comparable to that of the control cells (Figure 
4.27, 6 days). Gated cells in the granulocyte region showed a decrease of approximately 
20 % for cells stimulated with LPS, while cells stimulated with 30 and 45 µgml-1 of Con 
A showed a 10 % decrease compared with control cells. However, a large increase in 
the percentage of cells labelled with the mAb was seen with cells stimulated with Poly 
I:C, of approximately 20 % with respect to the control (Figure 4.27, 6 days). Numbers 
of labelled cells in RGran were comparable to the control (2.5 %) with the exception of 
Poly I:C stimulated cells where 6 % was recorded in this region (Figure 4.27, 6 days). 
When cells gated in the RPrecursor region were analysed, it was found that between 47 
and 57 % of cells were gated in this region for leukocytes stimulated with Con A 30 
and 45, and LPS 60 and 100, which was equivalent to increases of between 12-20 % 
with respect to the control. The fluorescent cells inside the RPrecursor region were 
only 2 % for Poly I:C stimulated cells, 10 % for the control cells and 21 % for Con 
A45 stimulated cells. For Poly I:C treated cells, the percentage of gated cells in 
RPrecursor was very low (i.e. 10 %) or 25 % lower than the control. The total 
percentage of labelled cells registered between 28 % for the Poly I:C treated cells, 34 % 
for the control, and a maximum of 41 % for the Con A30, 45 and LPS 60 treated cells 
(Figure 4.27, 6 days). 
 
 
 137 
 
 
Figure 5.22 Example dots plots of flow cytometry analysis of leukocytes from rainbow trout stained with mAb TcOm15 after 3 and 6 days 
of culture with Con A (30 µg ml-1), LPS (100 µg ml-1) or Poly I:C (100 µg ml-1). The delimitation for the regions R1 (or RLymph), R2 (or 
Rgran), and R3 (precursors and debris) is shown. Dots in green indicate positive cells, red dots indicate gated cells in R1 (RLymph), 
blue dots indicate gated cells in R2 (RGran), purple dots indicate gated cells in R3 (precursors or debris). 
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Figure 5.23 Flow cytometry analysis of rainbow trout leukocytes from head kidney 
(HKL) cultured for 3 and 6 days. Percentages of total positive cells (in green), gated 
cells in RLymph, and gated cells in RGran (negatives in blue and positives in 
green) from 10,000 events. Data from cultures with three different concentrations of 
Con A (15, 30 and 45 µg/ml), two of LPS (60 and 100 µg/ml), one concentration of 
Poly I:C (100µg/ml), and controls are shown. 
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When comparing the level of stimulation obtained over time, the main findings 
are that the number of cells in RLymph did not show an increase in the number of 
cells nor in the percentage of fluorescence. The mitogens Con A and LPS induced a 
decrease of the population gated in RGran, while Poly I:C was a strong promoter of 
activation for granulocytes. However, the number of cells labelled inside gate RGran 
showed a tendency to decrease from 13 % to 8 % following stimulation where the 
highest labelling was found for Poly I:C (Figure 4.24). The number of cells gated in the 
RPrecursor region increased by about 10 % over time for all mitogens except for Poly 
I:C, where very low levels were maintained. An increase of about 10 % was observed in 
the total number of fluorescing cells, attributable mainly to the precursor population 
(Figure 4.24). 
5.3.5 Effects of immunostimulation in vivo by Ergosan and β-glucan 
on expression of TcOm15+ cells.  
A total of 234 leukocyte samples isolated from 4 organs (PBL, thymus, spleen, 
and head kidney) were prepared from 56 fish sampled. However, unfortunately the 
samples were fixed in formalin/PBS prior to staining for FCM. This fixation step may 
have altered the staining obtained by denaturing the antigen binding to the mAb. The 
data obtained in FCM did not appear consistent, and it was difficult to differentiate 
between the various cell populations. Thus, only the total percentage of TcOm15+ 
cells was analysed. When the percentage of total fluorescing cells were analysed from 
the different organs, one fish fed with Ergosan and one fish fed with yeast for three 
days showed a high percentages of labelled cells, 22 % for the fish fed Ergosan (Figure 
4.28) and 14 % for the one fed yeast (Figure 4.25). After 14 days of 
immunostimulation with Ergosan, two out of five fish showed a high percentage of 
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staining in their thymocytes (40 % and 21 % respectively), while fish from day 0 and 
controls showed a maximum of 6% of staining (during the whole experiment) (Figure 
4.25 & Figure 4.26). No statistical differences were found between treatments or time 
in any of the populations of leukocytes. 
 
Figure 5.24 Percentage (± s.d.) of total TcOm15 positive cells from thymus leukocyte 
from rainbow trout fed with Ergosan (E) or β-glucan (Y) during 15 days. C, control; 
d, days post treatment. Six fish were evaluated for every sampling treatment and 
time point (n= 6 fish per treatment). 
 
 
Figure 5.25 Example dot plots for total cells labelled from thymus leukocytes of a) 
control trout fish after 14 days (3 %), and b) Ergosan fed trout after 14 days (30 % of 
staining). 
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5.4 Discussion 
Activation assays are widely used in mammals to evaluate the ability of 
organisms to respond to stimulation (Schwager & Schulze, 1997). For teleosts, 
activation has been observed for leukocytes from different tissues and different fish 
species (Passer et al., 1996; Scapigliati, Romano & Abelli, 1999; Sarmento et al., 2004; 
Moulana et al., 2008). In the present chapter the ability of TcOm15 mAb to detect 
modulation of the labelled molecule on Rainbow trout leukocytes by the activity 
promoted of different mitogenic conditions was evaluated.  
5.4.1 mHCA experiments 
In the mHCA, enhanced with LPS and Con A, detection of cells was very low 
(2 % above control for LPS and 4 % for Con A). Although there was little detection, 
the values of TcOm15+ cells obtained from three replicate wells were constant for 
each treatment, suggesting consistent expression of the antigen recognised by this mAb 
during culture (6 % above control for LPS and 8 % for Con A). While the results from 
the different experiments cited in the literature are not directly comparable, due to 
differences in the treatments used, variations in culture conditions, and the disease 
status of the fish are helpful for reference as these give an interesting comparison. 
Wang et al., (1997) found that Con A and LPS promoted effective activation of whole 
blood leukocytes from percichthyid bass indicated by a stimulation index of 4, measure 
by 3H-thymidine. Conversely, Scharsack et al. (2001) observed by FCM that after 5 days 
of culture leukocytes from Rainbow trout with Con A (30 µgml-1), the numbers of cells 
gated in the lymphoid region remain constant (431 cells for control and 429 for Con 
A).  The studies by Gauthier et al. (2003) showed that activation of leukocytes from 
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Rainbow trout revealed a maximum stimulation index of 2.  In the present study, the 
analysis of data from mHCA experiments shows that cell activation was not easily 
distinguished by just examining the total number of gated cells in a region. Detailed 
analysis of cells stained with mAb TcOm15 allowed different peaks of staining 
intensity to be detected (e.g. an intensity of 12.0 for the basal cell reaction in M3 and 4.0 
for Con A stimulated cells) (Table 4.2). The specific detected population in M3 showed 
a characteristic behaviour or modulation by the different concentrations of Con A, and 
due to the specific activity on T-cells, it is possible that this type of cells were involved. 
After one day of stimulation with 45 µgml-1 of Con A, the populations in the M3 were 
seen to increase in cell numbers but a considerable decrease in the antigen detection by 
mAb TcOm15, possibly due to a down regulation of the molecule, was also observed. 
After six days TcOm15+ cells were detected again (i.e. acquiring an intensity close to 
that of the controls, 8.9). When the same cells were stimulated with LPS, a down 
regulation of the detected molecule with the mAb was observed by the third day (e.g. 
12.0 Gmean intensity for basal reaction cells in M3 and 6.6 for LPS 45 µgml-1, Table 
4.2), but TcOm15+ cells were not detected after six days (control Gmean 13.4 and 
LPS 5.0). However, it is possible in this case that the dose of LPS used was not high 
enough to obtain activation. Higher concentrations have been shown to be needed to 
obtain activation of leukocytes (Wang et al., 1997; Kehrer, Hannan & Raison, 1998; 
Morrison et al,. 2004; Araki et al., 2007). The group of cells in M2 did not show 
stimulation, so there appears to be a lack of stimulation of these cells by Con A and 
LPS. Added to that, there appeared to be no effect of mitogens on the expression of 
the antigen detected by mAb TcOm15, so it is possible that the TcOm15 molecule is 
conserved in cells that are not stimulated by Con A or LPS. Meloni et al. (2006) 
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reported that the time necessary to obtain a two fold increase of T-cells in a HCA was 
two weeks. Taking this into account, it could be assumed that the time used for the 
experiments with mHCA (3 and 6 days) was not long enough to obtain higher peaks of 
response. Arkoosh, Clem & Casillas (1994), obtained similar negative or borderline 
positive activation of leukocytes in studies with Pleuronectes vetulus using a three way 
HCA, evaluated by 3H-thymidine after 5 and 7 days.  
In early studies on human immunology, identification of subpopulations of 
leukocytes was based on activation caused by Con A in MLR and in proliferation 
assays, and proved to be a very useful tool for the description of lymphocyte 
subpopulations (review Dwyer & Johnson, 1981). In the present study Con A and LPS 
on activation via foreign histocompatibility complex assays promoted stimulation and 
variation of TcOm15 molecule detection on the cells in M2, but a strong decreased 
detection in another group of cells (M3) by Con A stimulation that was recovered with 
the time. 
5.4.2 Stimulation of cells from individual fish 
To better understand the effects of activation on TcOm15 molecule detection 
by FCM, analysis of data from individual animals was performed. In general, it was 
observed that PWM and PMA had a more pronounced effect on TcOm15+ peripheral 
blood leukocytes from Rainbow trout. Because of different patterns of stimulation on 
leukocytes were detected on individual fish stimulated with mitogens, it is necessary to 
emphasized that the Rainbow trout used in these studies were families from a farm 
where records of breeds, diseases or treatments, that could have give an explanation 
for the individual variations, was not obtained. The results obtained agrees with the 
those observed by Kehrer, Hannan & Raison (1998) who found PWM to be a better 
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stimulator of peripheral blood trout leukocytes than mitogens such as Con A, LPS or 
PHA. PWM has the ability to stimulate both B and T-cells in mammals, and not just 
the specific populations stimulated by Con A, LPS or PHA (Ashraf & Khan, 2003). 
Even though individual fish showed different levels of activation and stimulation with 
the various mitogens used, a similar pattern of response was seen between fish. It is 
possible that the difference in the proportions of stimulation and expression is related 
with the immune status of the individual fish, but similar patterns of response, 
consistent within cell populations, were observed upon stimulated by the mitogens. 
Replication of assays, managing same periods of time under stimulation during 
experimentation, was a weak element during the thesis research where results obtained 
from experiments evaluated with confocal microscopy are no supported by FCM 
approach. Such sort, is the finding of two fold increased registration of mean intensity 
of Texas red conjugate on ConA stimulated TcOm15+ cells after 20 mins in relation 
with the mean intensity of DAPI staining the nuclei compared to the control. With this 
ratio calculation it was expected to indirectly find a relation of TcOm15+ staining with 
the amount of DAPI fluorescing in nuclei of cells. It was considered that this approach 
could be valid, in the absence of a reliable method to count single cells in a localised 
tridimensionally on the slide.  
5.4.3 PMA down-regulation 
An interesting reaction was observed with PMA stimulation for which the 
expression of TcOm15 molecule was totally lost. Phorbol esters act on biological 
membranes and have affinity for phospholipid membrane receptors and are activators 
of the protein kinase C enzyme (Ron & Kasanietz, 1999; Silinsky & Searl, 2003). In the 
present study a dose of 5 ng PMA was used to stimulate leukocytes from peripheral 
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blood and head kidney, however no obvious stimulation was obtained and this may be 
explained by the lack of addition of a cofactor such as Ca+ for PKC to enhance 
activation, though some studies have demonstrated that the addition of phorbol ester 
compounds can effectively activate leukocytes in fish (Lin et al., 1992; Blohm et al., 
2003). For mammals, activation has even been reported in a Ca+ independent pathway 
(Gelfand et al., 1985; Burnet & Schwarz, 1994). For the present study, the addition of 
PMA without Ca+ did not have any effect on activation, but strongly down regulated 
the expression of TcOm15. This down-regulation suggests that possibly the TcOm15 
molecule is related with changes promoted by PMA, either through the PKC pathway 
or an alternative phorbol receptor. It has been shown in humans that important 
receptors or molecules are down regulated by PMA. For instance, it is argued that the 
receptor for TNFα is down-regulated by PMA due to the redistribution of receptor 
caused by modifications in the cytoskeleton or by phosphorylation of the receptor 
(Aggarwal & Esssalu, 1987; Winzen et al., 1992; Kilpatrick et al., 2000). Another 
example molecule down-regulated by PMA is L-selectin; it is a molecule that mediates 
leukocyte homing through binding to ligands on vascular endothelial cells. This 
molecule, which is constitutively expressed on all virgin or naive leukocytes, but absent 
in a subset of effector or memory cells, is rapidly shed after activation with PMA 
(Kansas, 1996, Fors et al., 2001). The possibility that the TcOm15 molecules resemble 
one of these molecules (known down-regulated in humans) needs to be further 
investigated.  
5.4.4 Modulation of expression in organs 
The TcOm15+ leukocytes from peripheral blood and the thymus under the 
experimental conditions used were most sensitive to the action of stimulators. An 
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interesting result was the detection of an almost two fold increase of TcOm15+ cells 
with mitogens. Thymus leukocytes from fish have shown the ability to activate in the 
presence of PHA, as was observed by Rombout et al., (1997). However, differences in 
the amount of PHA exist between the dose from the present study (20 µgml1-) and the 
one cited by Rombout et al., (1997) (1 µgml1-). In humans, the culture of the thymic 
cells has been used to identify subpopulations of thymic cells (Forsdyke, 1969) and to 
examine how these subpopulations respond to stimulation to PHA. For instance, up-
regulation of CD4 molecules by PHA has been shown to be a marker to identify 
activated CD8+ cells, a controversial subpopulation of double positive T cells (DP T) 
(Sullivan et al., 2001). 
The high percentages of TcOm15+ found in vivo in some fish in the present 
study, may be a random finding not related to the immunostimulants administered, yet 
the thymic cells of these fish appeared to be stimulated with levels comparable to those 
found in vitro.  
Attempts to study the expression of the TcOm15 antigen from different organs 
with different mitogens by SDS-PAGE and Western blot failed probably because of 
the existence of mixed populations of cells and the ability of the mAb to detect 
cytoskeletal proteins. The presence of several leukocyte populations expressing 
TcOm15+ at different levels could mask the results. Alternatively, is possible that the 
dilution of the mAb TcOm15 was not appropriate to detect the proteins in the 
Western blots assays. The FCM results reflect the variation of the TcOm15 molecule 
during different treatments because the staining was used to detect molecules on the 
membrane of the cell and not internal antigens which would have required 
permeabilization of the cells. 
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The series of assays performed in this chapter should be considered as 
preliminary because of the low number of samples. used. However, the results 
obtained provide enough evidence to confirm that FCM is an ideal method to obtain 
valuable information as to the role of the molecule detected by the mAb TcOm15 and 
its apparent involvement in the activated state of leukocyte populations of Rainbow 
trout. In fact much of the research involving detection of markers on cells are initiated 
with assays that, by the continue experimentation, are improved. Further 
experimentation is necessary to corroborate the findings. 
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Chapter 6 General Discussion 
 
The differentiation of cell phenotype and function during an immune response has 
been made possible in mammals thanks to the availability of mAbs against cell surface 
markers (Mak & Saunders, 2006). For example, the activation of leukocytes is an 
important step in the inflammatory response in which the cells become primed to 
respond. Increased expression of some antigens or expression of new antigens occurs 
on the surface of the cells as they become activated, while the expression of other 
antigens is down-regulated.  
Unlike mammalian immunology, there are few mAbs to identify different cell 
markers on teleost leukocytes. However, great progress has been achieved in the 
knowledge of fish immune response thanks to advancements in molecular biology. 
Genes involved in the immune reaction of teleosts have been sequenced and 
characterised, allowing better interpretation of the mechanisms which occur during 
physiological changes in the humoral and cellular immune responses so as to maintain 
homeostasis. The main features of the immune response found in mammals have been 
also identified in teleosts, such as cellular responses (e.g. B-cells, T-cells, CD8, CD4, 
plasma cells, phagocytes, killer cells, etc.), and humoral mediators (antibodies, cytokines, 
lymphokines, chemokines, etc) (Castro et al., 2010; Maisey & Imarai, 2010). 
The aim of this research project was to develop a cell marker for the activation 
of Rainbow trout leukocytes that could be used to provide information about the 
function of leukocytes upon stimulation. To achieve this, the thymus of rainbow trout 
was selected as a source of leukocytes and used to immunise mice for MAb 
production. The thymus is important as a haematopoietic tissue and contains both 
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immature and mature forms of leukocytes (mainly T-cells). The leucocytes isolated 
from the thymus were first stimulated with a potent T-cell mitogen (e.g. Con A) prior 
to immunising the mice with the cells. The intention of this was to promote changes in 
the expression of functional molecules on the surface of the cells and against which the 
mouse antibodies would be produced.  
Selection of the MAbs during the screening process was based on the ability to 
detect surface antigens on thymic cells using a dot blot. Further screening was 
performed by FCM using PBL stimulated allogeneically with incompatible leukocytes 
in the presence of Con A. It was believed that this would allow the selection of mAbs 
that could recognise activated T-cells. The mAb TcOm15 was selected from the 
screening process and its ability to stain activated leukocytes assessed. Three main 
bands of protein were detected in Western blotting by this mAb, and these were 
identified by mass spectrometry as a cytoskeleton-related molecular complex consisting 
of non-muscle myosin, spectrin and actinin, and also as a immunoglobulin-like protein. 
Assays were evaluated by FCM in order to explore the ability of mAb TcOm15 to stain  
cells were performed, showing that cytometry is a valuable technique to detect changes 
associated with activation of Rainbow trout leukocytes.  
As explained above, the mAb of particular interest, produced during the study 
(i.e. mAb TcOm15) was originated from mice immunisated with thymic cells activated 
with Con A. The thymus is an organ where T-cells experience an ideal 
microenvironment for maturation, during which they acquire specific receptors (TcR 
and CD3) and antigens of differentiation (i.e. CD8+ or CD4+) on their surface, thus 
enabling them to respond to foreign antigens (Picchieti et al., 2009). Con A was used to 
activate mature T-cells so that they would express surface markers that were 
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phenotypically different to naive T-cells. The aim was to produce MAbs against these 
expressed antigens by immunising the mice with the activated cells.  
During the initial screening, only thymic cells were used to detect positive 
MAbs. In hindsight it may have been more useful to also have screened with spleen 
cells as well as the thymic cells, to improve the chances of selecting mAbs against only 
T-cells (i.e. mAbs that stained thymus but not spleen cells). Thus there was of an 
obvious risk that other potentially useful MAbs were missed during the screening 
process.  
The differences observed during screening by FCM with a basal or enhanced 
allogeneic reaction (multiple way histocompatibility activation, mHCA), stimulated 
with Con A, were important for the selection of mAb TcOm15, with differences 
possibly related with up-regulation of molecules on the surface of activated cells. The 
activation via foreign histocompatibility detection (HCA) for screening was a modified 
MLR reaction for which little information is available as a comparison. It is possible, 
that a better defined reaction may have allowed the detection of mAbs to specific cell 
populations (e.g. cytotoxic, non-cytotoxic cells). Even though the reaction has not been 
fully described elsewhere, it should still be considered as a useful assay for this study, 
especially because of the reproducibility of the results obtained within assays. Constant 
results were obtained between replicates, and mAb TcOm15 was shown to detect 
differences between the doses of Con A used (i.e. the more Con A used the fewer 
positive cells obtained). However, between assays there were differences, explained 
possibly because the proportions of participating cells during the HCA (modified 
MLR) reaction could have changed according to the number of responsive fish during 
the multiple way reaction. Unfortunately it was not possible to identify the cells 
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responding during this multiple-way reaction. However, the participation of cytotoxic 
T-cells would be expected during a allogeneic reaction, based on the findings of other 
authors (Meloni et al., 2006; Picchietti et al., 2008; Araki et al., 2008). The first 
impression obtained during initial cell screening by FCM was that a small population 
restricted to the lymphocyte region increased in number when stimulated with Con A. 
However, further work showed that the staining was not restricted to this small 
population of leucocytes. Lymphocyte-like, granulocytes-like and monocyte-like cells 
were stained and observed using confocal microscopy where it was possible to observe 
a mesh-like pattern (Lymphocyte-like cells) and dotted patterns of staining 
(granulocytes-like and monocyte-like cells).   
It appears that the mAb identified in this study did not recognise phenotypic T-
cells, but instead the molecule recognised by mAb TcOm15 seemed to be up-regulated 
during the allogeneic response enhanced by Con A stimulation. The role of the 
TcOm15 molecule in the MLR could be investigated further by isolating TcOm15+ 
cells and investigating the functional activity of these cells, such as cytotoxicity i.e. by 
blocking the antigen site with mAb TcOm15+ in order to stop its functional activity 
(e.g. by observing inhibition of cytotoxic activity). The incubation of cells with mAbs to 
evaluate functional activity of the molecules on the surface of cells has been used 
previously to investigate the inhibitory effects of anti-aggregatin found during 
phagocytosis by seabream macrophages (Mulero et al., 2001).  
The application of mAbs already available for rainbow trout leukocytes (as 
shown earlier in Table 1.3) to screen the cell populations labelled with mAb TcOm15 
may help provide information on the cells identity. This could permit separation or 
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enrichment of cells in order to evaluate their functional activity and allow relating the 
modulation observed with the labelled molecules on specific populations of cells.  
The detection of mAbs during the present study could have been improved by 
specifically looking for differences in functional cell populations during the screening 
with the mHCA. Assessments of functional activity should be included in future work 
aimed at developing mAbs against different cell populations, e.g. using phagocytic 
assays whereby the bacteria are labelled with fluorescence to monitor phagocytosis by 
macrophages, neutrophils, or even B-cells, and also screen to find potential markers by 
double fluorescence cytometry (Li et al., 2006; Overland et al., 2010). The importance 
of developing markers against functional states of cells would provide valuable tools to 
evaluate immunological states in vivo.  
A key factor preventing the development of mAbs against fish immune cells is 
the absence of relevant cell lines representing cellular components of the fish’s immune 
system. These would provide a means of standardising the assays used for screening 
and for comparing results between experiments and laboratories. In the present study, 
inconsistencies were found in the recognition of the molecule TcOm15, where cells 
were obtained from Rainbow trout from fish farms. For instance, where comparisons 
were made between individual fish or experiments repeated, differences in the 
proportions of cells labelled with the mAb cells were observed. The use of farmed fish 
in these experiments is not ideal because their history of disease or exposure to 
pathogens is unknown; their genetic background differences between fish and the 
environments the fish are cultured in also varies. In early studies performed for human 
cell marker development, great achievements were made using available cell lines. For 
example, the K562 human cell line (natural killer activity) (Moretta et al., 1981), T cell 
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lines CEM, HSB-2 and MOLT-4 (Reinherz et al., 1980), or Epstein-Barr virus-
transformed B lymphoblastiod cell line (Engleman et al., 1981) all contributed to such 
work. Although there have been advances in the number of mAbs against components 
of the immune response of catfish (Passer et al., 1996; Moulana et al., 2008) using cell 
lines for this species (Miller, Chinchar & Clem, 1994), there are few cell lines for 
teleosts. This is clearly an important area for future research. 
Staining of cells with mAb TcOm15 indicated that distinct cell types were 
recognised by the mAb, but the level of staining did not occur to the same extend with 
every cell. Stained cells showed defined staining in confocal analysis which appeared to  
co-localise with F-actin confirming the results obtained from mass spectrometry. 
According to the identification of the proteins that bind to mAb TcOm15 (i.e. a 200 
kDa molecule identified as Myosin; a 160 kDa molecule identified as non-erythroid α 
Spectrin and membrane bound Ig-like; and a 105 kDa molecule identified as α Actinin-
4), the cytoskeleton is highly implicated as the site where the antigen is detected. The 
results showed co-localization of the mAb with F-actin confirm this relationship and it 
was possible to observe changes on the pattern of staining (capping, polarization or 
dots) during mitogen stimulation; however no experiments to further probe this 
relationship were performed due to time constraints.  
The explanation given for the results of the confocal microscopy work is 
complicated by the fact that the proteins identified by spectrometry are ubiquitous for 
almost every type of cell present in fish, but it would appear that the reaction of mAb 
TcOm15 was restricted to only some cell populations. One explanation proposed is 
that mAb TcOm15 detects a specific site on a complex of proteins that it is being 
expressed or exposed during stimulation. Studies in mammals have demonstrated that 
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multi-proteins are related with important cellular functions of the cytoskeleton. The 
existence of a teleost multi-protein like the Trio complex in mammals may help to 
explain the detection of multiple cytoskeletal proteins by mAb TcOm15. Trio is a 
complex protein that contains two guanine nucleotide exchange factor domains, each 
one associated with pleckstrin homology domains (pleckstrin is a protein domain of 
approximately 120 amino acids that occurs in a wide range of proteins involved in 
intracellular signalling or as a constituent of the cytoskeleton), a serine/threonine 
kinase domain, two SH3 domains, an immunoglobulin-like domain, and spectrin-like 
repeats (spectrin repeats are found in several cytoskeletal proteins involved in the 
cytoskeletal structure). Originally, this Trio multi-protein was identified as a protein 
involved in actin remodelling, cell migration and cell growth (LAR tyrosine 
phosphatase-binding) (Debant et al., 1996; Medley et al., 2000). Different isoforms of 
the Trio complex have been described, for instance one expressed during leukaemia, or 
ones specifically found in the brain (i.e. Trio 9S and Trio 9L) (McPherson, Eipper & 
Mains, 2004). It possible that the antigen detected by TcOm15 could be a protein 
showing a conformation comparable to the Trio type, i.e. a multiprotein complex, that 
mAb TcOm15 is able to label at a specific antigenic site available in some leukocytes 
under specific conditions. Attempts to identify this multi-protein complex were 
unsuccessful (2D Blue Native PAGE, Chapter 3), and it was therefore necessary to 
analyse the proteins separately in mass spectrometry. It is possible that samples of 
protein lysates obtained for mass spectrometry analysis were not appropriate for 
identification of a multi-protein complex. Alternatively, relatively recent interpretation 
of results on mammal cellular activation confirms that cytoskeletal reorganization is 
essential for cell activation (Smith-Garvin, Koretzky & Jordan, 2009). This 
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rearrangement is necessary to polarize and form clusters of receptors at the stimulatory 
interface, where the identified cytoskeletal proteins for this study have been detected 
(example Figure 5.1). From another perspective, Ig superfamily domains are commonly 
found on the membrane surface of leukocytes as part of receptors, and have a high 
participation in cell to cell recognition (example Figure 5.2). Several studies have found 
that cytoskeletal proteins co-precipitate with receptors of leukocytes, and it is therefore 
possible that there is a strong association with some receptors and the group of 
proteins recognised by mAb TcOm15 (Pardi et al., 1992; Joseph & Samanta, 1993; 
Pavalko et al., 1995). 
 
 Figure 6.1 Model image of receptors of cell adhesion and associated components of 
the cytosekeleton. “Ig CAM cell adhesion receptors are depicted in association with 
their typical extracellular ligands and bound to the proteins that link them to the 
actin cytoskeleton” (from Barclay, 2003; page 221). 
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Figure 6.2 “Models for proteins interacting between T cells and antigen presenting 
cells. IgSF domains are indicated by red ovals. The sizes are based on structural 
data where available but otherwise the spatial arrangement of domains is 
speculation” (from Juliano, 2002; page 285). 
 
 
Different mitogens were employed to promote activation, with the aim of stimulating 
specific types of cells, with mitogens specific for those cell types. However, due to the 
low numbers of fish used and replication of samples, the results obtained from FCM 
were not consistent and should only be considered as preliminary results. It could be 
that inconsistencies obtained were as a result of differences in the physiological 
conditions required for each cell type. In general, recognition of TcOm15+ cells by the 
mAb was observed on cells under specific stimulation of the mHCA and mitogenic 
stimulation with Con A. The use of mitogens, on their own to non-specifically 
stimulate cells showed that the TcOm15 molecule was mainly located on circulating 
lymphocytes and thymocytes. However, the level of TcOm15+ cells observed in 
lymphocytes isolated from tissues such as head kidney or spleen did not change very 
much during these experiments. Even though the results are inconclusive, it is 
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considered that they do provide a good insight in to the potential of  mAb TcOm15 as 
a tool in FCM to evaluate the participation of the molecule detected under controlled 
conditions (cell lines, MLR assays, etc).  
The cells detected in this thesis by mAb TcOm15 cannot be described in terms 
of a phenotype cell population; however, due to the modulation in the labelling of cells 
observed with mitogen stimulation, it may be possible to define the molecule that the 
mAbs bind to in terms of function. The flow cytometry results and the anatomical 
preference of staining in the thymus observed by microscopy could possibly indicate 
the participation of the TcOm15 molecule during differentiation. However, further 
studies are necessary to investigate this possibility. 
Granulocytes are professional phagocytes that were poorly detected by mAb 
TcOm15, and no changes in the number of labelled cells were observed during 
mitogen stimulation. PMA and Poly I:C are substances that have been used to promote 
activation of macrophages or monocytes differentiation, and have been applied to 
peripheral blood leukocytes and head kidney cells (Tafalla & Novoa, 2000; Sarmento et 
al., 2004; Sepulcre et al., 2007). In the present study, low levels of staining of head 
kidney granulocytes with mAb TcOm15 was observed only with Poly I:C, while there 
was actually inhibition or down-regulation of the antigen recognised by the mAb in 
PBL. It is interesting to note that the results from mammalian studies showed PMA to 
activate monocytes when co-cultured with peripheral blood T-cells, and induced 
apoptosis in these T-cells (Wu et al., 1995). This is based on a possible explanation that 
monocytes activated by PMA induce apoptosis of cells through cell-to-cell contact of 
receptors. Another possibility is that cells are being stimulated by cytokines secreted 
from other cell populations present during the culture, after they were directly 
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activated by the mitogens. For instance, PMA treatment effects on co-cultured 
granulocytes could have promoted the activation of the cells resulting in the release of 
factors (e.g. cytokines) that produced the down-regulation of the molecule in another 
co-culturing population of cells sensitive to these factors. Studies with activation 
factors like PMA and antagonist of activation through protein kinase C in leukocyte 
cultures to elucidate the cause of the strong down-regulation of TcOm15 molecule are 
required.  
Development of markers for cellular components of the immune response of 
fish has been the subject of many studies over the past few decades (Secombes et al., 
1987). However, success in these endeavours has been poor, partly due to the diversity 
of fish species examined, and the numerous surface molecules that could be detected 
and described (without counting cytosolic or soluble molecules). The results suggest 
that this task needs to be performed by numerous groups of scientists, with the 
intention of characterising molecules that show modulation during the immune 
response. The search for key cell markers in fish that are equivalent to the markers 
known in mammals has been limited to research on molecules such as CD8+, TcR, etc., 
possibly restricting the development of novel markers for teleosts. Thus, potential 
markers for leukocyte function may have been overlooked, because they do not fulfil 
the characteristics of markers that phenotypically differentiate between populations of 
mammalian leukocytes. Paradoxically, new explanations are being given for 
mechanisms known in mammals and old paradigms have been renovated (e.g. double 
positive CD4 and CD8 populations, Zloza & Al-Harthi, 2006). Therefore, there is a 
risk in expecting the same structure and function of molecules as cell markers in fish to 
those found in mammals, even when their immune systems share many important 
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features. For example, the existence of B cells has been shown for both fish and 
mammals, but phagocytic behaviour has only been reported in B cells of fish (Li et al., 
2006; Overland et al., 2010). Thus in retrospect, it may have been more advantageous 
to describe causes, effects or events related to specific molecules, based on the broad 
knowledge that already exists for mammals, looking for similarities but not 
equivalences. Once a collection of mAbs is available and used to elucidate the immune 
response of fish, equivalent mechanisms between fish and mammals may be found, 
and those specific for teleosts can be described.  
Functional studies are a valuable source of information for the characterisation 
of new mAbs developed as cell markers for fish, and for elucidating the role of actively 
functioning molecules in the immune response of fish. The mAb TcOm15 developed 
in the present study has the potential to be a useful tool to detect changes related with 
cytoskeleton, but elucidation of the role of the molecule detected by the mAb TcOm15 
still requires further research.  In order to define the applicability of mAb TcOm15 as a 
marker, future research could be performed to determine regulation of the molecule 
during remodeling of the leukocyte cytoskeleton for synapses (i.e. cell to cell 
communication) or migration. FCM together with confocal microscopy are invaluable 
for investigating cytoskeleton modification upon leukocyte activation and would be 
ideal for use in future work.  
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